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INTRODUCTION 
 
Urine is considered an ideal source of biomarkers, since it can be 
obtained non-invasively,  in large amounts and it is rich in molecules 
important for clinical diagnostics. In human medicine the study of the 
urine proteome started in 1979 and in 2004 the first reference map of 
the normal urine proteome was reported. However, in veterinary 
medicine the literature is fragmentary and a complete study on the 
urine proteome in companion and farm animals is still lacking.  
The aim of the present work is to produce a complete analysis of 
the urine proteome in animals of veterinary interest, dogs, cats, horses 
and cows including also some non-conventional species. In particular, 
the aims were to:  
- validate high resolution electrophoresis (HRE) to quantify 
albuminuria in dogs and cats 
- apply SDS-PAGE and 2DE coupled to mass spectrometry to 
produce a complete reference map of the urine proteome in 
healthy cats and compare it to cats affected by chronic kidney 
disease to identify putative biomarkers of nephropathy; 
- apply SDS-PAGE coupled to mass spectrometry to characterize 
the urine proteome in healthy dogs and compare it to dogs 
affected by leishmaniasis to identify putative biomarkers of 
nephropathy;  
- apply SDS-PAGE to characterize the urine proteome in dairy 
cows and evaluate changes during pregnancy; 
- apply SDS-PAGE to characterize the urine proteome in healthy 
horses and compare it to diseased horses;  
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- quantify proteinuria and apply SDS-PAGE to characterize the 
urine proteome in non-conventional species (felids and giraffes) 
to evaluate kidney function and the general health status. 
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1. PART I: STATE OF THE ART 
 
1.1. URINE PROTEOME IN HUMAN MEDICINE 
 
Biomarkers are any measurable characteristics that reflect a particular 
physiological or pathophysiological state. More specifically, a clinical 
biomarker indicates a change in expression or state of a molecule that 
correlates with the risk or progression of a disease, or with the 
susceptibility of the disease to a given treatment. Ideally, a biomarker 
should be sensitive and specific, accurate and precise, non invasive 
and applicable to different population groups, due to variations related 
to age, gender or races.   
Urine is considered one of the most easily accessible source of 
biomarkers, since it can be obtained in large quantities, in non-
invasive ways and it is rich in molecules important for clinical 
diagnostics. The first studies on normal urine composition were 
performed in 1979, applying two-dimensional electrophoresis  (2DE) 
at a time in which the term proteomics had not been coined yet 
(Anderson et al., 1979). The term proteome, which is a synthesis of 
the words protein and genome, was coined in 1996 by a PhD student 
trying to describe the set of all proteins that could be produced 
through the genome in a certain tissue (Wilkins et al., 1996). Thus, the 
term urinary proteome describes the entire set of proteins possibly 
present in the urine.  
Urine, produced by healthy kidneys, normally contains only a 
small amount of proteins since large molecules are not able to pass the 
glomerular filter and most of the small molecular weight proteins and 
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protein fragments are reabsorbed along the tubular system. The 
abnormal presence of proteins in urine, which can derive either from 
plasma filtration or kidney damage, is known as proteinuria. 
Therefore, from a proteomic point of view, proteinuria can provide 
information on the systemic physiology (from serum proteins) as well 
as local physiology (from the proteins produced by kidneys).  
The definition of the normal urine protein map is the starting 
point for the biomarker discovery. After the first study in 1979, 
proteomic techniques and in particular, 2DE coupled with mass 
spectrometry (MS), have been significantly improved and extensively 
applied for the purpose. Pieper et al., (2004) reached the observation 
of 1400 protein spots in urine, identifying the 30% of them. In the 
same year  Oh et al., (2004) defined a preliminary urine proteome map 
(Figure 1).  
 
Figure 1. 2DE of the urine proteome (Oh et al., 2004). 
 
Recently, a number of large-scale proteomics studies have been 
carried out to characterize the urinary proteome from healthy 
individuals. Marimuthu et al., (2011) compared the list of proteins 
identified in their study with two other large-scale studies, one by 
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Adachi et al., (2006) that reported 1543 proteins and another by Li et 
al., (2010) that reported 1310 proteins (Figure 2). Common proteins 
identified to all these three studies were 658 and represent the most 
commonly identifiable proteins in human urine. Combining all the 
data from the studies published to date, in human urine are present at 
least 2500 different proteins and peptides.   
 
 
Figure 2. Venn diagram comparing large scale studies on urinary proteome (Marimuthu et al., 
2011).  
 
The proteins identified in normal urine can be classified in 
specific groups following a functional criteria. Kidney secretory and 
structural proteins, serum and transport proteins,  coagulation and 
complement factors, immunoglobulins and other immune proteins, 
enzymes, metal binding proteins and lipoproteins are only some of the 
possible functional groups (Candiano et al., 2010).  
Finally, the most challenging class of proteins of which urine is 
rich in is low abundance proteins. Most of the low abundance proteins 
in normal urine are still to be characterized. The most innovative 
techniques that are now developing are based on beads coated with 
hexameric peptide ligand libraries. The benefit of concentrating urine 
prior electrophoresis is that the most abundant proteins, such as 
albumin, are eliminated with a higher efficiency than low abundance 
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ones. Therefore, equalization offers a good chance for improving our 
knowledge on the composition of the normal urine proteome and 
move towards the biomarker discovery (Decramer et al., 2008; 
Candiano et al., 2010).  
Many of the identified proteins in large-scale proteomics studies 
on normal urine are now under investigation in more specific and 
applied clinical trials to validate their use as sensitive and specific 
biomarkers of diseases. Chronic kidney disease (CKD), acute kidney 
injury (AKI) and diabetic nephropathy (DN) are only three of the 
diseases extensively studied in human medicine by the application of 
proteomic techniques. Lhotta, (2010) discussed the role of uromodulin 
during CKD. Good et al., (2010) identified an array of urinary 
biomarkers for accurate diagnosis of CKD using capillary 
electrophoresis coupled to mass spectrometry (CE-MS) and 
subsequently validated it. Devarajan, (2011) largely discussed some of 
the newly discovered biomarkers of AKI. Metzger et al., (2010) have 
identified twenty urinary peptides significantly associated with AKI, 
including fragments of albumin, α-1-antitrypsin and β-2-
microglobulin proving that a proteomic classifier based on these 20 
biomarkers would be of superior prognostic value in comparison to 
common single biomarkers of AKI. Regarding DN, Meier et al., 
(2005) applied CE-MS to urine samples of Type 1 diabetic patients 
revealing a specific clusters of 54 polypeptides. Also Andersen et al., 
(2010) applied CE-MS to study the low molecular weight (LMW) 
proteome in hypertensive type 2 diabetic patients with 
microalbuminuria to monitor the antihypertensive medication. They 
identified that the most prominent changes involved urinary collagen 
fragments associated with progression of diabetic nephropathy, 
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suggesting that a major benefit of treatment was the improvement of 
collagen turnover and the reduction of fibrosis. 
The usefulness of the urine proteome as source of biomarker is 
important also for  non-kidney related pathophysiology. A first 
example is the study of Zheng et al., (2013) on urine samples collected 
from pregnant and non-pregnant women. The proteome was analyzed 
by SDS-PAGE coupled with high resolution MS. In total, 2579 
proteins were identified and 16 phosphoproteins were found to be 
significantly differentially expressed just before delivery. Other 
examples regards cardiovalscular disease extensively reviewed by 
Delles et al., (2011) or hypertension (Carty et al., 2013).  
 
1.2. URINE PROTEOME IN VETERINARY MEDICINE 
 
In veterinary medicine, the application of proteomics techniques is 
still limited. Most of the studies focused on the identification and 
quantification by western blot or ELISA of select proteins, e.g. 
uromodulin or retinol binding protein, extensively studied in human 
medicine (Raila et al., 2007; Smets et al., 2010).  
Recently, there have been significant efforts to study the urine 
proteome in dogs (Forterre et al., 2004; Nabity et al., 2011; Schaefer 
et al., 2011) and to a lesser extent in cats (Lemberger et al., 2011; 
Jepson et al., 2013; Ferlizza et al., 2015). In particular, Nabity et al., 
(2011) applied 2DIGE coupled to MS on urine samples to identify 
specific proteins related to tubulo-interstitial injury in a canine model 
of progressive glomerular disease. In another study, surface-enhanced 
laser desorption/ionization time-of-flight mass spectrometry (SELDI-
TOF MS) was used to perform protein-level profiling of urine from 
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dogs with and without renal disease (Forterre et al., 2004). Schaefer et 
al., (2011) applied SDS-PAGE to urine samples of dogs affected by 
severe inflammatory response syndrome (SIRS). Only in 2014 Miller 
et al., (2014) reviewed data on biological fluid in dogs and Brandt et 
al., (2014) published a complete characterization of the dog urine 
proteome.  
Regarding the urine proteome in cats, the literature is even more 
fragmentary. Jepson et al., (2013) reported the application of SELDI-
TOF to low molecular weight proteins in urine of cats at risk of 
developing azotemia. Another study with a proteomic approach 
referred to urine samples in cats affected by urinary tract disease, 
idiopathic cystitis (IdC), bacterial urinary tract infection (UTI), or 
urolithiasis (Lemberger et al., 2011). Recently, a preliminary 
characterization of the urine proteome in healthy cats and the 
comparison with cats affected by CKD has been published (Ferlizza et 
al., 2015). 
The many applications of proteomics in farm animals has been 
recently reviewed (Almeida et al., 2015).  
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2. PART II: EXPERIMENTAL STUDY 
 
2.1. VALIDATION AND PROTOCOL OPTIMIZATION 
 
2.1.1. HIGH RESOLUTION ELECTROPHORESIS (HRE) TO 
QUANTIFY ALBUMINURIA 
 
2.1.1.1. MATERIALS AND METHODS 
Samples 
This study was performed using urine samples of dogs and cats 
submitted to the Veterinary Clinical Pathology Service (SEPAC VET) 
of the Veterinary Teaching Hospital (Department of Veterinary 
Medical Sciences - University of Bologna) for different clinical 
conditions without selecting for age, sex, underlying disease or 
method of collection.  
 
Urinalysis (USG, dipstick and sediment) 
Each urine sample underwent complete routine urinalysis 
including the determination of the urine specific gravity (USG) by a 
refractometer, the semi-quantitative dipstick test (Combur10Test, 
Roche Diagnostic) and the microscopic sediment analysis at low 
(100x) and high (400x) power field. 
 
Protein quantification  
Urine total proteins were determined using commercial kits 
(Urinary/CSF Protein, OSR6170) on an automated chemistry analyzer 
(AU 400, Olympus/Beckman Coulter). Dog urines were also analyzed 
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by an immune-turbidimetric assay (ITA) developed for human 
albuminuria (Microalbumin OSR6167, Olympus/Beckman Coulter) 
and validated for dog urine (Gentilini et al., 2005).  
 
High resolution electrophoresis (HRE) 
For all urine samples were performed high resolution 
electrophoresis (HRE) on 0.8% agarose gel at pH 8.6 (HydraGel HR 
15, SEBIA) in combination with the semi-automated system 
HYDRASYS (SEBIA), according to the manufacturer instruction. The 
gels were dried, stained by acid violet solution and acquired by the 
EPSON PERFECTION V700 PHOTO scanner/densitometer. The 
obtained pherograms were analyzed by the Phoresis software (version 
6.1.2) and the albumin percentage calculated. The relative percentage 
and absolute concentration of albumin was calculated based on the 
density determined by the densitometer. As reported by the 
manufacturer, the limit of detection of this technique in serum is 1.5-2 
mg/dL for albumin (0.15 to 0.2 micrograms per band), with dosages 
linear up to at least 5.8 g/dL and optimal protein concentration of 200 
mg/dL. Urine samples with higher protein concentration were diluted 
in order to achieve the desired optimal concentration. 
 
Validation   
Within-assay variability was assessed on five cat urine samples 
(albumin concentrations 7.4; 13.4; 23.5; 38.8; 67.7 mg/dL) and on one 
dog urine sample (115.3 mg/dL). Samples were run five times on the 
same gel.   
15 
 
Between-assay variability was evaluated measuring four cat 
urine samples (7.4; 13.4; 23.5; 67.7 mg/dL) and one dog urine sample 
(137.2 mg/dL) three times in triplicate on three different days. 
 Linearity was tested by serial dilutions of one cat urine sample 
(79 mg/dL) and one dog urine sample (154.6 mg/dL) until the 
expected albumin concentration under the limit of detection (LOD) 
defined by the manufacturer (1.5 mg/dL) was reached. Each sample 
was made in duplicate. It was also possible to define the analytical 
sensitivity of HRE, evaluating both LOD (limit of detection, the 
lowest concentration with a visible albumin band on the gel) and LOQ 
(limit of quantification, the lowest concentration with a recognizable 
and quantifiable peak in the pherogram without interferences).  
To evaluate accuracy, in the absence of a reference method for 
cat albuminuria,  the recovery test was performed by adding to 100 µL 
of a cat urine (alb 24.5 mg/dL) 100 µL of two cat urines (alb 83.3 
mg/dL; alb 41.7 mg/dL) and saline. The three solution high (H), 
medium (M) and low (L) had 53.75 mg/dL, 32.95 mg/dL e 12.1 
mg/dL of expected albumin. Five measurement were made. In dog 
urine, albuminuria measured by HRE was compared to ITA validated 
for dog (Gentilini et al., 2005) and used in clinical practice.  
 
Statistical analysis  
Statistical analysis was performed with MedCalc ® 11.3.3.0 and 
Excel 2007. Precision was evaluated by the calculation of the 
coefficient of variation (CV) as follows: CV=(SD/mean)X100. Linear 
regression analysis was used to evaluate the correlation between 
albumin expected and measured values and between HRE and ITA for 
dogs. Bland and Altman plot was also used to evaluate the accordance 
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between HRE and ITA. P-value was considered significant when less 
than 0.05.  
 
2.1.1.2. RESULTS 
Dog  
HRE had within-assay CV of 1.37%, between-assay CV of 
5.67% and a high linearity (r=0.99) (Table 1 and Figure 1).  It was 
also possible to visually define LOD at 1.2 mg/dL of expected 
albumin and LOQ at 4.9 mg/dL. The comparison between HRE and 
ITA was performed by linear regression analysis and Bland and 
Altman plot (Figure 2). Data showed a highly significant correlation 
(P<0.0001). The Bland and Altman plot showed that HRE 
overestimated values lower than 50 mg/dL, while values higher than 
100mg/dL were underestimated. In particular, some of the analyzed 
samples showed greater discrepancies between albumin values 
measured by ITA and HRE. Data are reported in Figure 3 and Table 2.  
 
Table 1. Between-assay and within-assay CVs for dog albuminuria measured by HRE. 
 
Between-assay Within-assay 
Mean (mg/dL) 137.24 115.27 
SD (mg/dL) 7.77 1.58 
CV % 5.66 1.37 
 
a)  b)  
Figure 1. HRE (a) and correlation plot (b) showing linearity for dog albuminuria. 
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Figure 2. Bland and Altman plot for comparison between HRE and ITA. 
 
a)   
 
b)  
Figure 3. HRE (a) and pherograms (b) of urine samples that showed great discrepancies with ITA 
as reported in table 2. 
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Table 2. Data regarding urine samples (Figure 3) that reports discrepancies between ITA and HRE. 
Lane and 
pherogram 
Alb % Alb (mg/dL) UTP 
(mg/dL) HRE ITA HRE ITA 
1 35 73.9 211 460 623 
2 53 76.1 153 218 288 
3 49 90.1 97 179 199 
4 38.8 73.5 194 368 502 
UTP: urine total portein 
 
Cat  
Table 3 reported data for within-assay and between-assay 
variability and recovery percentage. HRE had all CVs under 10% 
ranging from 2.58% to 7.6% for within-assay and from 1.2% to 9.1% 
for between-assay. Figure 4 reported some examples of gels. HRE 
showed high linearity (r=0.99; Figure 5) between expected and  
measured albumin values and the recovery percentage was of 97%, 
93% and 109% for H, M and L concentration respectively. It was 
possible to define optically the LOD at 1.25 mg/dl of expected 
albumin and by densitometry the LOQ at 5 mg/dl (Figure 5).  
 
Table 3. Between-assay and within-assay CVs and recovery percentage for albuminuria in cat 
measured by HRE. 
WITHIN-ASSAY 
 
Mean (mg/dL) 67.73 38.83 23.50 13.37 7.40 
SD (mg/dL) 1.75 2.26 0.81 0.99 0.56 
CV % 2.59 5.81 3.44 7.40 7.60 
BETWEEN-ASSAY 
     
Mean (mg/dL) 67.25 24.53 13.23 7.10 
 SD (mg/dL) 2.37 0.29 0.98 0.64 
 CV % 3.52 1.20 7.45 9.06 
 
RECOVERY PERCENTAGE 
   
 
H M L 
  
Expected albumin (mg/dL) 53.75 32.95 12.1 
  
Measured albumin (mg/dL) 51.9 30.6 13.2 
  
Recovery % 96.6 92.9 109.1 
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a)  b)  
c)  
Figure 4. HRE of: a) within-assay, albumin 39mg/dL; b) within-assay, albumin 23.5 mg/dL; c) 
between-assay albumin, 7 mg/dL.  
 
 
a) b)  
Figure 5. Linearity (a) and LOD and LOQ (b) for albuminuria measured by HRE. 
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2.1.1.3. DISCUSSION 
In human patients proteinuria and albuminuria have been 
identified as independent risk factors for all-cause and cardiovascular 
mortality as well as adverse renal outcome in diabetic nephropathy 
and CKD (Wu et al., 2012). In veterinary medicine, albuminuria can 
be measured by a species-specific point-of- care, semiquantitative test 
(e.g., the Heska ERD-Health-Screen Urine test) and quantitative 
immunoassay at reference laboratories (Antech Diagnostics and Heska 
Corporation) (Grauer, 2011). A sensitive immuno-turbidimetric 
method for the quantification of albuminuria has been validated only 
for dogs  (Gentilini et al., 2005).  In the present study, HRE was 
validated to quantify albuminuria in dogs and cats. All the parameters 
evaluated (within and between-assay CVs <10%; recovery 97-109%; 
linearity, accuracy and correlation with ITA P<0.05; LOQ 5 mg/dL) 
can be considered satisfactory for a semiautomatic technique (Jensen 
and Kjelgaard-Hansen, 2006). However, the software of the 
densitometer was not able to perform an effective pherogram in 
sample with low amount of urine total protein (40 mg/dL) probably 
due to noise interferences, such as dust or gel irregularities as reported 
by Ferlizza et al., (2012) and Giori et al., (2011). Moreover, it was 
possible to compare data obtained by HRE in dog samples with 
adequate amount of proteins to data obtained by ITA showing a 
significant correlation. ITA validated in dog (Gentilini et al., 2005) is 
based on the high homology between human and dog albumin and on 
the cross reactivity between the anti-human albumin antibody and the 
dog albumin. The manufacturer reported that ITA is linear only in the 
range between 0.5 and 30 mg/dL, suggesting the dilution of samples 
with higher concentration. In contrast, our data showed that HRE is 
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linear for albumin in urine between 5 and 154 mg/dL and the 
manufacturer claimed HRE linear up to 5.8 g/dL for albumin in 
serum. Therefore data reported in the present study let us suggest that 
HRE could be more reliable than ITA for albumin quantification 
higher than 30 mg/dL, while ITA due to its higher sensitivity is more 
accurate for microalbuminuria.  
 
2.1.2. TWO-DIMENSIONAL ELECTROPHORESIS (2DE) 
 
2.1.2.1. MATERIAL AND METHODS 
Samples 
This study was performed using urine samples of pigs and cats 
submitted to the Veterinary Clinical Pathology Service (SEPAC VET) 
of the Veterinary Teaching Hospital (Department of Veterinary 
Medical Sciences – University of Bologna) for different clinical 
conditions without selecting for age, sex, underlying disease or 
method of collection.  
 
Urinalysis (USG, dipstick and sediment) 
Each urine sample underwent complete routine urinalysis 
including the determination of the urine specific gravity (USG) by a 
refractometer, the semi-quantitative dipstick test (Combur10Test, 
Roche Diagnostic) and the microscopic sediment analysis at low 
(100x) and high (400x) power field. 
 
 
 
 
22 
 
Protein quantification 
Urine total proteins were determined using a commercial kit 
(Urinary/CSF Protein, OSR6170) on an automated chemistry analyzer 
(AU 400, Olympus/Beckman Coulter).  
 
Protocol optimization for sample preparation 
To remove salts and concentrate proteins,  150 µg of proteins 
underwent three different protocols: 
- a) Acetone precipitation: one volume of cold acetone 20% was 
added to one volume of pig urine to a final concentration of 
10%,  incubated at -20°C overnight and centrifuged at 15,000 g 
for 30 min; 
- b) TCA/ethanol precipitation: one volume of trichloroacetic 
acid  20% was added to one volume of pig urine to a final 
concentration of 10% in gentle shaking for one hour at 4°C, 
centrifuged at 15,000 g for 30 min and washed three times with 
cold absolute ethanol; 
- c) Ultrafiltration: 1.5 mL of pig urine were loaded in 
Vivaspin500 spin columns (Sartorius Stedim Biotech) with a 
molecular weight (MW) cut-off of 3 kDa and centrifuged at 
15,000 g of 30 min; 500 µL of water was added to the retenate 
and centrifuged again up to reach a final volume of 100 µL. 
The pellets were dissolved in a solubilisation buffer (SB) containing 7 
M urea, 2 M thiourea, 4% CHAPS w/v, 65 mM DTT and 0.8% 
resolytes v/v (pH 4-7) before loading onto immobilized pH gradient 
(IPG) strips (pH gradient 4-7, 11 cm long) (BioRad). IPG strips were 
rehydrated, equilibrated and placed on top of 4-15% acrylamide gel. 
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2DE protocol optimization for animal urine proteome 
To optimize the 2DE protocol, two urine samples from healthy and 
CKD cats were analyzed with 3 different protocols:  
- Protocol 1: 200 µg of protein, IPG strip 7 cm and pH 3-10, 
poliacrylammide 12%; 
- Protocol 2: 100 µg of protein, IPG strip 7 cm and pH 4-7,  
poliacrylammide 10%; 
- Protocol 3: 300 µg of protein, IPG strip 17 cm and pH 3-10, di 
poliacrylammide 10%  
 
2.1.2.2. RESULTS 
Protocol optimization for sample preparation 
Figure 6 reports the 2DE of the three different methods used to 
prepare samples. The best resolution was obtained by the TCA/ethanol 
precipitation with the greatest number of visible spots. The acetone 
precipitation protocol did not allow the precipitation of proteins and 
none spots is visible. The protein concentration reached after 
ultrafiltration was not adequate and lower than that obtained by the 
TCA/ethanol precipitation.  
 
a)  
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b)  
c)  
 Figure 6. 2DE of pig urine after the three  protocols tested to concentrate and desalt urine. a) 
Acetone precipitation; b) TCA/ethanol precipitation; c) ultrafiltration.  
 
2DE protocol optimization for cat urine proteome 
Figure 7 reported the 2DE of the three different protocol used to 
separate cat urine proteome.  
a)  
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b)  
c)  
Figure 7. 2DE of healthy and CKD urine samples by means of (a) protocol 1, (b) protocol 2 and (c) 
protocol 3. Blue circles highlighted spots more evident in healthy; red circles highlighted spots 
more evident in CKD; yellow circles highlighted common spots. 
 
The protocol 1 did not allow an optimal separation and 
visualization of the protein spots due to excessive protein amount. In 
particular, acidic and high MW proteins (>80 kDa) were not optimally 
visualized. 
The protocol 2 allowed an optimal visualization of protein spots 
at intermediate MW and in the acidic pH range. Moreover, high MW 
proteins (>80 kDa) were also optimally visualized. However, basic 
and low MW proteins (<20 kDa) where excluded.  
The protocol 3 allowed an optimal separation of urine protein 
covering a wide range of MW and pH. Differences between healthy 
and CKD cats were also highlighted.  
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2.1.2.3. DISCUSSION 
The clinical interest of urine as an easily accessible biological 
fluid rich in potential markers of disease is largely approved. In 
human medicine many studies focused on urine proteome and applied 
2DE for biomarker discovery (Candiano et al., 2010). However, urine 
matrix can be an important source of interferences due to the high 
amounts of salts and urea that can negatively affect sensitivity and 
spot resolution. In addition, due to low amount of proteins, 
particularly in samples from healthy animals, protein concentration is 
an essential step before electrophoretic separation. Therefore the 
sample pre-treatment procedure and the optimization of the 2DE 
protocol are essential (Martin-Lorenzo et al., 2014).  
First, we tested the influence of three different methods to desalt and 
concentrate samples for 2DE profiling. Only the TCA/ethanol 
precipitation allowed the visualization of high number of spots, while 
the other methods did not permit an optimal spot visualization. Our 
data on pig and cat urine proteome differed from what reported for 
humans where all the pre-treatment procedures tested allowed a good 
resolution and high sensitivity (Martin-Lorenzo et al., 2014).  
Secondly, we optimized the protocol for the better separation of the 
urine proteome trying different pH ranges and polyacrylamide gel 
concentration. In this case, all the protocol tested, except for the first 
where too much sample was loaded, allowed a satisfactory spot 
resolution. Therefore, depending on the pH and MW range of interest 
and the specific proteins to be investigated any of the protocols may 
provide satisfactory data in term of resolution.   
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2.2. COMPANION ANIMALS 
 
2.2.1. DOG URINE PROTEOME 
 
2.2.1.1. MATERIALS AND METHODS 
Animals and samples 
For the present study, healthy dogs and dogs affected by 
leishmaniasis (Leish) were selected. The healthy group included dogs 
presented to the Veterinary Teaching Hospital of the Faculty of 
Veterinary Medicine - University of Extremadura, Spain, and to the 
Veterinary Teaching Hospital of the Department of Veterinary 
Medical Sciences - University of Bologna. Animals considered 
healthy on the basis of history and physical examination and with no 
history of urinary tract diseases were included. For the diseased group 
were selected dogs with leishmaniasis diagnosed on the basis of 
history, clinical signs and clinico-pathological results. The diagnosis 
of leishmaniasis was confirmed by the presence of amastigotes in 
cytology specimens or anti-leishmania antibody detection, given with 
Indirect ImmunoFluorescence assay (IIF) with the positivity higher 
than 1/80;  
Upon arrival, all the animals were subjected to physical 
examination and routine laboratory tests, including complete blood 
count, serum chemistry and complete urinalysis with urine protein and 
urine albumin to creatinine ratios (UPC; UAC). Five millilitres of 
urine were collected from each animal by ultrasound-guided 
cystocentesis and analyzed with the following standardized protocol: 
 urinalysis (USG and dipstick); 
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 centrifugation at 1,500 g for 10 minutes; 
 microscopic analysis of urine sediment; 
 protein quantification with UPC and UAC ratios calculation; 
The supernatants were immediately stored at -80 ˚C for the subsequent 
analysis by high resolution electrophoresis (HRE) and SDS-PAGE.  
 
Urinalysis (USG, dipstick and sediment) 
Each urine sample underwent complete routine urinalysis 
including determination of the urine specific gravity (USG) by a 
refractometer, semi-quantitative dipstick test (Combur10Test, Roche 
Diagnostic) and microscopic sediment analysis at low (100x) and high 
(400x) power field. 
 
Protein and albumin quantification 
Urine total proteins (UTP) and creatinine were determined 
using commercial kits (Urinary/CSF Protein, OSR6170, and 
Creatinine OSR6178, Olympus/Beckman Coulter) on an automated 
chemistry analyzer (AU 400, Olympus/Beckman Coulter). Urine 
albumin was determined by an immuno-turbidimetric assay (ITA) 
developed for human albuminuria (Microalbumin OSR6167, 
Olympus/Beckman Coulter) and validated for dog urine (Gentilini et 
al., 2005). This method is linear from 0.5 mg/dL to 30 mg/dL and the 
limit of detection is 0.046 mg/dL. The UPC and UAC were calculated 
with the following formula: UPC or UAC = urine protein or albumin 
(mg/dL)/urine creatinine (mg/dL) 
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High resolution electrophoresis (HRE) 
Urine samples were analyzed on precast 0.8 % agarose gel at 
pH 8.6 (HydraGel 15 HR, SEBIA) for quantification of albuminuria as 
previously described (Ferlizza et al., 2012). The kit was used in 
combination with the semi-automated HYDRASYS system (SEBIA). 
The gels were subsequently stained with an acid violet solution, dried 
and scanned by a densitometer (EPSON PERFECTION V700 
PHOTO) yielding the pherogram (Phoresis 6.1.2 software). The 
relative percentage and absolute concentration of albumin were 
calculated based on the density determined by the densitometer. The 
limit of detection of this technique is 5 mg/dL for urine albumin with 
an optimal UTP of 200 mg/dL. Urine sample with UTP higher than 
200 mg/dL were diluted in order to achieve the desired optimal 
concentration. The values obtained were compared with data obtained 
by the automated method. 
 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Urine proteins were separated using the electrophoresis 
NuPAGE system (Thermo Fisher Scientific) on 12% polyacrylamide 
gel in 3-(N-morpholino) propanesulphonic acid (MOPS) buffer with 
sodium-dodecyl-sulphate (SDS) (Thermo Fisher Scientific). Two µg 
of proteins for each sample were loaded. The gels were stained with 
SilverQuest (Thermo Fisher Scientific). After staining, each gel was 
digitalized and its pherogram was obtained using GelAnalyzer 2010 
software1. To have a better visualization of low molecular weight 
(MW) protein bands and to prepare for mass identification, 10 µg of 
                                                 
1
 http://www.gelanalyzer.com/ 
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proteins of eight urine samples were also analyzed using the Criterion 
system (BioRad) on a 16.5 % polyacrylamide gel in Tris-glycine 
buffer with SDS. The gel was stained with Coomassie blue staining 
(PageBlu protein staining solution; Thermo Fisher Scientific) 
compatible with mass spectrometry. 
 
Protein identification by mass spectrometry 
Protein identification was performed at the Department of 
Diagnostic, Clinical and Public Health Medicine, University of 
Modena and Reggio Emilia.  
Protein bands were excised manually from the gels and 
subjected to in-gel tryptic digestion as previously described (Bellei et 
al., 2013). After digestion, the peptides were analyzed by a Nano LC-
CHIP-MS system (ESI-Q-TOF 6520, Agilent Technologies).  
Protein-identification peak lists were generated using the 
Mascot search engine against the UniProt database2 as previously 
described (Bertoldi et al., 2013). Proteins with a score hits >60 or 
identified with at least two or more significant peptide sequences were 
selected. The significant threshold in Mascot searches was set in order 
to obtain a False Discovery Rate <5% (5% probability of false match 
for each protein with a score above 60).  
  
Statistical analysis 
Data were analyzed with statistical software (MedCalc 
Statistical Software version 12.7.5) and expressed as median and 
(range) or mean±standard deviation (SD). The different variables 
                                                 
2
 www.uniprot.org 
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(albumin mg/dL, UPC, UAC, number of bands) were tested for 
normality with Shapiro-Wilk normality test and compared using the 
Kruskal-Wallis one-way analysis of variance assuming P<0.05 as a 
significant probability. Samples measured by HRE with urine albumin 
lower than 5 mg/dL were considered as 4.9 and the UAC were 
calculated according to this value. Spearman’s rank correlation test 
was used to establish correlation between HRE and ITA. 
 
2.2.1.2. RESULTS 
Animals and samples 
Thirteen entire dogs (7 males, 6 females) were included in the 
study as the healthy group. The median age was 36 months (15-84) 
and median UPC and UAC were 0.07 (0.05-0.19) and 0.005 (0.001-
0.015) respectively. 
Twenty-six dogs affected by leishmaniasis (10 entire females, 
14 entire males and 2 neutered males) were included in the 
Leishmania group (Leish). Leish dogs had a median age of 48 months 
(12-108) and had significantly increased UPC (median 2.1; 0.06-20.8) 
and UAC (0.29; 0.003-6.2) values than healthy dogs (P<0.01) (Figure 
1). Plasma biochemistry and urinalysis data are reported in Table 1. 
 
a) b)  
Figure 1. Graphs reporting (a) UPC and  (b) UAC data for healthy and Leish dogs.  
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Table 1. Clinical data for dogs affected by leishmaniasis (n = 26). 
Signalment Mean±SD n 
 
Age in months 48±27 
  
Female (entire/neutered) 
 
10 (10/0) 
 
Male (entire/neutered) 
 
16 (14/2) 
 
Plasma biochemistry Mean±SD n (%) < or >RI RI  
Total Proteins (g/dL) 8.2±2.2 1(4)< 16(62)> 5.3-7.6 
Albumin (g/dL) 2.8±0.8 16(62)< 3.2-4.7 
Creatinine (mg/dL) 1.8±2.6 10(37)< ; 8(31)> 0.5-1.4 
Urea (mg/dL) 95±97 10(37)> 18-55 
Phosphorus (mg/dL) 96.7±4.6 1(4)< 5(19)> 1.9-7.9 
Urine biochemistry Mean±SD n (%) < or >RI RI 
UPC  3.2±4.3 15(58)> <0.5 
UAC 1.6±3.1 17(65)> <0.03 
USG  1.029±0.014 15(58)< >1.030 a 
Clinical signs 
 
n (%) 
 
Lymphadenopathy 
 
20(77) 
 
Dermatological lesions 
 
17(65) 
 Apathy / Depression 
 
15(58) 
 Weight loss 
 
13(50) 
 Anorexia 
 
9(35) 
 Onychogryphosis 
 
8(31) 
 
Lameness / Joint pain 
 
7(27) 
 Nasal Hyperkeratosis 
 
7(27) 
 
PU/PD 
 
7(27) 
 
Diarrhea 
 
6(23) 
 
Vomiting 
 
6(23) 
 
Dehydration 
 
5(19) 
 
Bloody Diarrhea 
 
3(12) 
 
Epistaxis 
 
3(12) 
 
Pale mucosas 
 
3(12) 
 
Ocular lesions 
 
2(8) 
 
RI, reference interval; UPC, urine protein to creatinine ratio; UAC, urine albumin to creatinine 
ratio; USG, urine specific gravity. a Considered as adequate USG in cats. 
 
HRE and albuminuria 
Representative gels and pherograms of urine samples of healthy 
and Leish dogs are reported in Figure 2. In samples with protein 
concentration higher than 40 mg/dL it was possible to qualitatively 
evaluate the protein content, separating different protein fractions, 
 showing different profiles bet
quantifying albuminuria. UAC measured with HRE was significantly 
correlated with ITA (
 
a)    
d) 
Figure 2. Representative HRE of urine samples of (a) healthy and (b) 
a Leish sample. d) Correlation between ITA and HRE for albuminuria.
 
In particular, healthy samples showed a fain
and a diffused band between alp
dogs showed more evident bands and in some cases the profile was
similar to the serum electophoretic profile (Figure 2b
In Leish group i
electrophoretic profile during the therapy.  Figure 3 reported 
comparison among urine samples from the same patient at different 
time intervals. Lanes 2 and 3 showed the renal functionality 
improvement after one and two months post
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ween healthy and Leish
P<0.01) (Figure 2d).  
 
b)   c) 
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miltefosine; in these two lanes a decrease in albumin fraction and alfa 
zone is evident. Six months after the diagnosis, lane 4, albumin is still 
absent while the other fractions are slightly increased. 
 
 
Figure 3. HRE of urine samples of the same patient at the moment of diagnosis T0 (1) and after the 
end of treatment with miltefosine (2,3,4) in the same patient. In lanes 2,3 and 4 the patient was 
treated with allopurinol.  
 
Figure 4 reported electrophoretic profiles of two urine samples 
from the same dog during treatment (lane 1) with miltefosine and 
allopurinol and two months later after the end of treatment (lane 2). 
During the treatment the renal damage seems downgrading, but only 
two months later the electrophoretic pattern highlights a stronger 
damage with more albumin loss and an increased intensity of α, ß and 
ɣ zones. 
 
Figure 4. HRE of urine samples during (1) and after (2) treatment with miltefosine and allopurinol.  
 
SDS-PAGE 
Urine samples from the 13 healthy and 26 Leish dogs were 
analyzed by SDS-PAGE. Representative gels and pherograms are 
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reported in Figure 5. We separated 28±5 protein bands in the urine of 
healthy dogs. Most protein bands had an apparent MW between 17 
and 67 kDa. The Leish group presented a greater inter-individual 
variability and a greater number of bands at MW between 66 and 10 
kDa. A significant increase of the total number of bands (37±9) 
(P<0.05) was observed, particularly at MW lower than 67 kDa 
(P<0.01) (Figure 6).  
 
a) b)  
Figure 5. Representative (a) gels and (b) pherograms of urine samples of healthy (2-3) and Leish 
(4-5) dogs.  
a) b)  
Figure 6. Comparison of the number of protein bands between healthy and Leish dogs. (a) Total 
number of bands. (b) Number of bands with MW<67 kDa. 
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SDS-PAGE allowed to evaluate changes in the urine proteome 
during the treatment. Examples of specimen before and after treatment 
are reported in Figure 7 and 8. Figure 7 reported urine samples of the 
same patient before and after treatment with miltefosine and 
allopurinol. Increase of the 90 kDa band and the decrease of the bands 
of 67 kDa as well as the band in the zone between 64 and 14 kDa can 
be appreciated.  
 
 
Figure 7. SDS-PAGE of a Leish dog (1) before and (2) after treatment.  
 
Figure 8 reported urine samples of the same patient during and 
two months after treatment with miltefosine and allopurinol. During 
the treatment the renal damage is downgrading, but two months later 
the electrophoretic pattern highlighted a stronger damage. 
 
 
Figure 8. SDS-PAGE of a Leish dog (1) during and (2) after treatment.  
 
Figure 9 reported SDS-PAGE of urine samples loaded with 
increasing UPC from healthy (lane 2) and Leish non proteinurics 
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(lanes 3) to borderline (lanes 4-9) and proteinurics (lanes 10-15). The 
decrease of the band at 90 kDa (green rectangle) and the increase of 
three bands at 76, 67 and in some samples at 15 kDa (red rectangles) 
are clearly evident.   
 
Figure 9. SDS-PAGE of urine samples loaded with increasing UPC. Lane 1, MW marker; 2, 
healthy; 3, non proteinuric Leish dog; 4-9 (UPC<0.2), borderline proteinuric Lesih dog (UPC 0.2-
0.5); 10-15, proteinuric Leish dogs (UPC>0.5). Green rectangle indicate the band at 90 kDa that 
showed decrease intensity in parallel to the increase of UPC; red rectangles indicate the bands at 
67, 67 that showed increased intensity in parallel to the increase of UPC and the band at 15 kDa in 
bordeline Leish dogs. 
 
Protein identification by mass spectrometry  
Eight urine samples from healthy and Leish dogs were 
separated on 16.5% SDS-PAGE in order to achieve a better separation 
of proteins at MW<67 kDa for subsequent MS identification. Figure 
10 reported the protein bands (n=7) of healthy and Leish dogs excised 
from the gel for MS identification. Table 2 reported the identified 
proteins.  
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Figure 10. SDS-PAGE of urine samples from healthy and lesih dogs. Lanes 1-2, healthy samples; 
lanes 3-6, borderline proteinurics Leish dogs (UPC 0.2-0.5); lanes 7-8 proteinuric Lesih dogs 
(UPC>0.5); lane 9 MW marker. Rectangles and numbers indicate the bands that have been cut and 
identified by ESI-Q-TOF (Table 2). 
 
Table 2. Proteins identified in dog urine by mass spectrometry. 
Band a Entry name b Protein full name MW 
c
 
(kDa) pI Score 
d
 Pept e Seq f Sign. Seq. g 
1 UROM_CANFA Uromodulin 73 4.94 2298 138 15 13 
2 UROM_CANFA Uromodulin 73 4.94 1546 114 16 13 
3 ALBU_CANFA Albumin 69 5.52 5802 470 44 39 
4 ALBU_CANFA Albumin 69 5.52 7408 453 54 44 
5 HPT_CANFA Haptoglobin 37 5.72 1526 198 18 14 
6 ESTA_CANFA Arginine esterase 29 8.03 532 111 10 9 
 
ESTA_CANFA Arginine esterase 29 8.03 448 81 9 8 
7 NPC2_CANFA Epididymal 
secretory protein 16 8.25 419 99 8 6 
 
SODC_CANFA Superoxide dismutase [Cu-Zn] 16 5.70 243 22 3 3 
a
 Number of the identified band or spot as marked in Figure 10. 
b
 Protein entry name from UniProt knowledge database. 
c
 Theoretical protein molecular weight. 
d
 The highest scores obtained with Mascot search engine. 
e
 Peptides: total number of peptides matching the identified proteins. 
f
 Sequence: total number of sequences matching the identified proteins. 
g
 Significant sequences: total number of significant sequences matching the identified proteins. 
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From the seven bands, six proteins were identified (Table 2, 
Figure 10). In particular, uromodulin (90 kDa) was identified in both 
healthy and Leish dogs showing a progressive decrease parallel to the 
increase of UPC (Figure 9). Albumin, corresponding to the band at 67 
kDa, showed increased intensity parallel to the increase of proteinuria. 
Band 6 and 7 contained 3 proteins, namely arginine esterase, 
epididymal secretory protein and superoxide dismutase. In our 
samples, this band showed a significant increase in 5 of the 6 
bordeline proteinuric Leish dogs. Haptoglobin was also identified in 
the band at 38 kDa. 
 
2.2.1.3. DISCUSSIONS 
The aim of this study was to evaluate the usefulness of HRE 
and SDS-PAGE in the separation of the urine proteome in dogs 
affected by leishmaniasis compared to healthy.  
HRE allowed the separation of different pherograms between 
healthy and Leish dogs, highlighting the increase of albumin and 
gamma zone in Leish dogs. The increase of globulinemia is a 
significant feature of leishmaniasis, mostly due to the increase of IgG 
(Proverbio et al., 2014). Electrophoresis of serum samples from 
leishmaniotic patients pointed out a polyclonal gammopathy, due to 
the host response versus the parasite. In urine, the presence of  high 
levels of all protein fractions, mostly of albumin, due to the renal 
damage, and gamma fractions, IgG (Solano-Gallego et al., 2003), due 
to host-response, can help during the follow-up of the leishmaniotic 
patient. A decrease of albuminuria could also indicate a downgrading 
of renal damage. 
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SDS-PAGE enabled the visualization of many protein bands 
due to the higher resolution power and the higher sensitivity of silver 
staining, particularly in healthy samples where low abundance 
proteins were completely undetectable by HRE. In this study we 
achieved an optimal separation of medium to low MW proteins in 
healthy samples as compared with data reported in literature where 
only uromodulin and albumin were reported (Figure 11) (Zaragoza et 
al., 2003; Raila et al., 2007). Accordingly, in our study the most 
represented protein in urine samples from healthy dogs was 
uromodulin, the most consistent band of high MW. Uromodulin  is a 
glycoprotein produced in the thick ascending limb of Henle's loop and 
in the early distal convoluted tubules. Uromodulin is involved in 
different physiological, e.g. water reabsorption, immunosuppression, 
protective role against bacterial infection, and pathological, e.g. 
urolithiasis, tubulointerstitial nephritis, processes (Youhanna et al., 
2014). The role of uromodulin in dog urine is still not completely 
known and some studies highlighted a decrease of this protein in dogs 
affected by renal disease (Forterre et al., 2004; Raila et al., 2007;  
Buono et al., 2012). In the present study, SDS-PAGE coupled with 
MS was essential to demonstrate the decrease of uromodulin in Leish 
dogs. Moreover, some patients showed an increase of uromodulin 
during treatment, indicating a downgrading of tubular damage. 
Therefore, this protein could be used during the follow-up of patients 
affected by leishmaniasis as a biomarker of positive response of the 
pharmacological treatment.  
 
 a) 
Figure 11. SDS-PAGE of dog urine samples. 
 
Among the proteins identified in 
esterase (ESTA). ESTA is a member
secreted by the canine prostate and has 58% h
human prostate specific antigen (PSA). PSA is a known marker of 
prostate carcinoma in men but its use in dogs is still controversial. 
ESTA is the major secretory product of the cani
to be a diagnostic marker of non
(Gobello et al., 2002)
canine bladder and in transitional cell carcinoma 
Recently ESTA has been identified also in urine of male dogs 
(Schellenberg and Mettler, 2008
2014). We cannot exclude the presence of ESTA as a finding related 
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b)  
a) Zaragoza et al., (2003). b) Raila et al., (
Leish dogs was found arginine 
 of the kallikrein
omology with the 
ne prostate and seems 
-neoplastic prostatic disorders 
. Other authors found ESTA activity of normal 
(LeRoy 
; Hormaeche et al., 2014; Miller et al., 
 
2007). 
 gene family 
et al., 2004). 
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to the presence of entire male dog in the Leish group. Nevertheless,  
its role in the canine prostate disorders is not yet understood and 
additional studies are needed to unreveal the role of ESTA also in 
dogs urine.  
Among the other proteins evidenced by SDS-PAGE comparing 
to data reported in literature for humans, dogs and cats we could 
hypothesize the presence of different proteins that showed different 
intensities between healthy and Leish dogs. The band at 76 kDa 
(putative transferrin) present also in healthy dogs increased in Leish 
dogs as well as the bands at MW>100 kDa. The presence these 
proteins in urine samples could be an important finding to highlight 
the glomerular damage as reported in literature (D’amico and Bazzi, 
2003). 
Other bands of apparent MW of 55 and 26 kDa (putative heavy 
and light chains of IgG)  were found in our patterns; the presence of 
these protein bands could be considered as markers of glomerular 
damage as previously described in the study conducted by Zaragoza et 
al. (2003) on patients affected by leishmaniasis. 
In Leish dogs we found many bands in  the MW range between 
55 and 17 kDa. Among them the only one identified by MS was 
haptoglobin (41 kDa).  Other proteins that could be present due to 
their MW and their possible role as biomarkers are alpha-1-
microglobulin (A1mG) (33 kDa) and retinol binding protein (RBP) 
(22kDa). A1mG is a clinical marker for the detection and 
differentiation of proteinuria. Physiologically, A1mG passes the 
glomerulus and is subsequently reabsorbed by the tubule. High levels 
of A1MG in urine indicate a tubular dysfunction and has been 
highlighted in dogs with nephropathy  (Yalçin and Çetin, 2004). RBP 
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is an interesting marker of tubular impairment recently studied in dogs 
(Maddens et al., 2010) and cats (van Hoek et al., 2009).  
In addition, other proteins at low MW (<14kDa) were found in 
our samples. Woo et al., (1991) characterized human proteinuria with 
SDS-PAGE evidencing a correlation between the presence of low 
MW bands and a high incidence of chronic renal failure, tubular 
atrophy and tubulo-interstitial lesions. Bazzi et al., (1997) found an 
association between the presence of low MW proteins and high serum 
creatinine concentration, pathological proteinuria and severe tubulo-
interstitial damage in patients with a primary glomerulonephritis. 
Furthermore in the same study they found a positive correlation 
between the presence of low MW bands and chronic renal failure 
progression and was also assessed that the response to 
pharmacological treatment was lower in patients with low MW 
proteins.  
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2.2.2. CAT URINE PROTEOME 
 
2.2.2.1. MATERIALS AND METHODS 
The present study on cat urine proteome is published on The 
Veterinary Journal and can be cited as: Ferlizza et al., 2015. The effect 
of chronic kidney disease on urine proteome in the domestic cat (Felis 
catus). Vet J. Doi: 10.1016/j.tvjl.2015.01.023 
 
Animals and samples 
For the present study healthy cats and cats affected by chronic 
kidney disease (CKD) were selected. The healthy group included 
entire cats presented to the Veterinary Teaching Hospital of the 
Department of Veterinary Medical Sciences – University of Bologna 
for neutering. Only animals considered healthy on the basis of history 
and physical examination and with no history of urinary tract diseases 
were included. For the diseased group were selected cats with CKD 
diagnosed on the basis of history, clinical signs, clinico-pathological 
and imaging results, according to Bartges, (2012). In particular, cats 
had to have (1) clinical findings of CKD, (2) persistent pathological 
renal proteinuria based on the urine protein to creatinine ratio, 
assessed and confirmed over a two-month period (UPC > 0.2), and (3) 
a serum creatinine concentration ≥1.60 mg/dL and urine specific 
gravity (USG)<1.035. CKD cats were staged according to 
International Renal Interest Society (IRIS) guidelines 3. Upon arrival, 
all the animals were subjected to physical examination and routine 
laboratory tests, including complete blood count, serum chemistry and 
complete urinalysis with UPC and urine culture. Five millilitres of 
                                                 
3
 http://www.iris-kidney.com/guidelines/  
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urine were collected from each animal by ultrasound-guided 
cystocentesis and analyzed with the following standardized protocol: 
 urinalysis (USG and disptick); 
 centrifugation at 1,500 g for 10 minutes; 
 microscopic analysis of urine sediment; 
 protein quantification with UPC ratio calculation; 
The supernatants were immediately stored at -80 ˚C for the subsequent 
analysis by high resolution electrophoresis (HRE),  SDS-PAGE and 
2DE.  
 
Urinalysis (USG, dipstick and sediment) 
Each urine sample underwent complete routine urinalysis 
including determination of the urine specific gravity (USG) by a 
refractometer, semi-quantitative dipstick test (Combur10Test, Roche 
Diagnostic) and microscopic sediment analysis at low (100x) and high 
(400x) power field. 
 
Protein quantification and urine protein to creatinine ratio (UPC) 
Urine total proteins (UTP) and creatinine were determined 
using commercial kits (Urinary/CSF Protein, OSR6170, and 
Creatinine OSR6178, Olympus/Beckman Coulter) on an automated 
chemistry analyzer (AU 400, Olympus/Beckman Coulter). The UPC 
was calculated with the following formula: UPC = urine protein 
(mg/dL)/urine creatinine (mg/dL).  
 
High resolution electrophoresis (HRE) 
Urine samples were analyzed on precast 0.8 % agarose gel at 
pH 8.6 (HydraGel 15 HR, SEBIA) for quantification of albuminuria as 
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previously described (Ferlizza et al., 2012). The kit was used in 
combination with the semi-automated HYDRASYS system (SEBIA). 
The gels were subsequently stained with an acid violet solution, dried 
and scanned by a densitometer (EPSON PERFECTION V700 
PHOTO) yielding the pherogram (Phoresis 6.1.2 software). The 
relative percentage and absolute concentration of albumin were 
calculated based on the density determined by the densitometer. The 
limit of detection of this technique is 5 mg/dL for urine albumin with 
an optimal UTP of 200 mg/dL. Urine sample with UTP higher than 
200 mg/dL were diluted in order to achieve the desired optimal 
concentration. 
 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
 Urine proteins were separated using the NuPAGE system 
(Thermo Fisher Scientific) on 4-12% polyacrylamide gel in 2-(N-
morpholino)ethanesulphonic acid (MES) buffer with sodium-dodecyl-
sulphate (SDS) (Thermo Fisher Scientific). Two µg of proteins for 
each sample were loaded. The gels were stained with SilverQuest 
(Thermo Fisher Scientific). After staining, each gel was digitalized 
and its pherogram was obtained using GelAnalyzer 2010 software4. 
To evaluate differences between genders, two pools were prepared by 
collecting and mixing 20 µg of proteins from each healthy male (n=8) 
and female (n=15) sample. The pools were concentrated by 
Vivaspin500 spin columns (Sartorius Stedim Biotech GmbH) with a 
molecular weight (MW) cut-off of 3 kDa and separated by SDS-
PAGE with the protocol reported above, with the exception of 3-(N-
                                                 
4
 http://www.gelanalyzer.com/ 
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morpholino)propanesulphonic acid (MOPS) buffer and Coomassie 
blue staining (PageBlu protein staining solution; Thermo Fisher 
Scientific) compatible with mass spectrometry analysis. 
 
Two-dimensional electrophoresis (2DE)  
Two-dimensional electrophoresis was performed at the 
Interdisciplinary Centre of Marine and Environmental Research, 
University of Porto, and at the Chemical and Biological Technologies 
Institute of the New University of Lisbon. 
Urine samples from four healthy and four CKD cats were 
selected for 2DE. To concentrate and desalt samples, 150 µg of 
protein for each sample were precipitated with trichloroacetic acid to a 
final concentration of 10% in gentle shaking for one hour and then 
centrifuged at 15,000 g for 30 min at 4 °C. The protein pellets were 
washed three times with cold absolute acetone, air-dried and dissolved 
in a rehydration buffer containing 7 M urea, 2 M thiourea, 4% 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 
65 mM dithiothreitol (DTT) and 0.8% resolytes (pH 3-10) before 
loading onto immobilized pH gradient (IPG) strips (non-linear pH 
gradient 3–10, 17 cm long) (BioRad). IPG strips were rehydrated and 
equilibrated following Campos et al., (2013). The equilibrated IPG 
strips were placed on top of 10% acrylamide gel, and protein 
separation was run at 24 mA per gel for 6 h in Protean II XL (BioRad) 
in running buffer containing 25mM Tris, glycine 192 mM and SDS 
0.1%, pH 8.8 (Campos et al., 2013). At the end of each run, the gels 
were stained by Coomassie Brilliant Blue (CBB). 2DE gels were 
digitalized in a GS-800 calibrated densitometer (Bio-Rad) and the 
images analyzed by Progenesis SameSpot software (Non-Linear 
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Dynamics) as described (Cruz DE Carvalho et al., 2014). All gels 
were aligned to the reference gel and the spots with an area less than 
or equal to 350 and an average normalized volume of less than or 
equal to 2000 were removed from the spot analysis. The volume of 
each spot over the volume of all spots in the gel was used for 
comparison of all groups by an analysis of variance (anova) test for n 
observations (n =4) to assess quantitative differences.  
 
Protein identification by mass spectrometry 
Protein identification was performed at the Department of 
Diagnostic, Clinical and Public Health Medicine, University of 
Modena and Reggio Emilia. Protein bands and spots were excised 
manually from the gels and subjected to in-gel tryptic digestion as 
previously described (Bellei et al., 2013). After digestion, the peptides 
were analyzed by a Nano LC-CHIP-MS system (ESI-Q-TOF 6520, 
Agilent Technologies). Data were acquired in data-dependent MS/MS 
mode in which, for each cycle, the three most abundant multiply 
charged peptides (2+ to 4+), above an absorbance threshold of 200 in 
the MS scan (m/z full scan acquisition range from 100 to 1700), were 
selected for MS/MS (m/z tandem mass spectrum acquisition range 
from 50 to 1700). Each peptide was selected twice and then 
dynamically excluded for 0.1 min. Raw mass spectrometry data were 
processed with MassHunter Qualitative Analysis B.05.00 software to 
obtain the Mascot generic files for database searching using the 
following parameters: deisotope, Absolute Height ≥10, Relative 
Height ≥ 0.1% of largest peak.  
Since the domestic cat protein database is not well annotated, 
we chose to search a broader taxonomy, namely “all mammals”, to 
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allow the identification on the basis of the sequence homology. 
Protein-identification peak lists were generated using the Mascot 
search engine against the UniProt database5 specifying the following 
parameters: Mammalian taxonomy, parent ion tolerance ± 20 ppm, 
MS/MS error tolerance ± 0.12 Da, alkylated cysteine as fixed 
modification and oxidized methionine as variable modification, and 
two potential missed trypsin cleavages, as previously described by 
Bertoldi et al., (2013). Proteins with a score hits >60 or identified with 
at least two or more significant peptide sequences were selected. The 
significant threshold in Mascot searches was set in order to obtain a 
False Discovery Rate <5% (5% probability of false match for each 
protein with a score above 60).  
 
Statistical analysis  
Data were analyzed with statistical software (MedCalc 
Statistical Software version 12.7.5) and expressed as median and 
(range) or mean±standard deviation (SD). The different variables 
(albumin mg/dL, UPC, UAC,  age, number of bands) tested for 
normality with the Shapiro-Wilk normality test and were compared 
using the Kruskal-Wallis one-way analysis of variance assuming 
P<0.05 as a significant probability. Samples with urine albumin lower 
than 5 mg/dL were considered as 4.9 and the UAC were calculated 
according to this value.  
 
 
 
 
                                                 
5
 www.uniprot.org 
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2.2.2.2. RESULTS 
Animal selection and UPC 
Twenty-three entire cats (8 males, 15 females) were included in 
the study as the healthy group. The median age was 24 months (6-
168) and median UPC was 0.11 (0.06-0.19). 
Seventeen cats (5 neutered females, 8 neutered males and 4 entire 
males) were included in the CKD group. CKD cats were significantly 
older with a median age of 168 months (60-240; P<0.01) and had a 
significantly increased UPC value (median 0.9; 0.25-6.5) than healthy 
cats (P<0.01). Plasma biochemistry and urinalysis data are reported in 
Table 1. 
 
HRE and albuminuria 
Figure 1 reports HRE of urine samples of healthy and CKD cats 
with the respective pherograms. In urine samples with total protein 
concentration higher than 40 mg/dL it was possible to separate 
different protein fractions. Different profiles between healthy and 
CKD cats were obtained. In particular, healthy urine samples showed 
a faint band of albumin and a diffused band between alpha and beta 
zone. Differently, CKD cats showed more evident bands and in some 
cases the pherogram was similar to the serum electrophoretic profile. 
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Table 1. Clinical data for cats affected by CKD (n = 17). 
Signalment Mean±SD n  
Age in months 160±64   
Female (entire/neutered)  5 (0/5)  
Male (entire/neutered)  12 (4/8)  
Plasma biochemistry Mean±SD n (%) < or >RI RI 
Total Proteins (g/dL) 7.9±0.8 6(35)> 6.0-8.0 
Albumin (g/dL) 3±0.4 4(24)> 2.1-3.3 
Creatinine (mg/dL) 5.9±3.6 17(100)> 0.8-1.6 
Urea (mg/dL) 264±148 16(94)> 15-60 
Phosphorus (mg/dL) 9.5±5.7 9(54)> 2.9-8.3 
Urine biochemistry Mean±SD n (%) < or >RI RI 
UPC 1.29±1.52 14(82)> <0.4 
USG 1.018±0.012 15(88)< >1.035 a 
IRIS Stage  n (%)  
II  4(24)  
III  4(24)  
IV  9(53)  
Clinical signs  n (%)  
Disorexia/anorexia  15(88)  
Polyuria/polydipsia  11(65)  
Depression  7(41)  
Weight loss  4(24)  
Abnormal renal palpation  3(18)  
Oral lesions  3(18)  
Vomiting  2(12)  
Weakness  2(12)  
Dehydration  2(12)  
Diarrhoea  1(6)  
Blindness  1(6)  
RI, reference interval; UPC, urine protein to creatinine ratio, USG, urine specific gravity. a 
considered as adequate USG in cats. 
 
a) b)  
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c)  
Figure 1. HRE of (a) healhty and (b) CKD urine samples with respective pherograms (c)  
 
HRE allowed the quantification of albuminuria as previously reported 
(Ferlizza et al., 2012) and data for albumin concentration in mg/dL 
and UAC are reported in Table 2. Healthy group showed significant 
lower values of albumin mg/dL and UAC (P>0.01) than CKD (Figure 
2).  
 
Table 2. Data for albumin concentration in mg/dL and UAC for healthy and CKD cats. 
 
HEALTHY CKD 
 
Mean±SD Median (range) Mean±SD Median (range) 
ALB mg/dL 9.22±7.84 4.9 (4.9-33.1) 21.3±28.3 9.5 (4.9-116.9) 
UAC 0.029±0.030 0.018 (0.008-0.12) 0.25±0.29 0.18 (0.05-1.3) 
  UAC, urine albumin to creatinine ratio 
 
a) b)  
Figure 2. The plots reported data for albumin concentration in (a) mg/dL and (b) UAC for healthy 
and CKD cats. For a better visualization the highest UAC value for CKD (1.3) was excluded from 
the graph. 
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SDS-PAGE 
Representative gels and pherograms from healthy and CKD cats 
are reported in Figure 3. We separated 32±6 protein bands in the urine 
of healthy cats. The majority had a molecular weight (MW) between 
10 and 80 kDa. The CKD group presented a greater inter-individual 
variability and typical tubular pattern, characterized by protein bands 
at MW<64 kDa. A significant decrease of the total number of bands 
(25±6) (P<0.01) was observed (Figure 4a), particularly at MW higher 
than 100 kDa (P<0.01) (Figure 4b and 5b). 
 
a)  
54 
 
b)  
Figure 3. SDS-PAGE of cat urine samples. a) Representative gel (lane 1, MW marker; lanes 2–7, 
urine samples from CKD cats; lanes 8–9, healthy urine samples) and (b) pherograms are shown.  
 
a)  b)  
Figure 4. Comparison of the number of protein bands between healthy and CKD cats. (a) Total 
number of bands. (b) Number of bands with MW>100 kDa. Different lower cases indicate 
significant differences (P<0.01). 
 
No significant differences were found between pooled urine samples 
collected from healthy males and females (Figure 3a). In Figure 5 is 
reported the gel used for the preparative separation of urines from two 
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CKD samples (lanes 2-3) and from male and female pooled urine 
(lanes 4-5 respectively). The most representative and reproducible 
protein bands (n=16) from healthy and CKD samples were excised 
from the gel for MS identification (Figure 5,Table 3).  
 
 
Figure 5. SDS-PAGE of urine samples from healthy and CKD cats. Lane 1, MW marker; lanes 2–
3, CKD urine samples; lanes 4–5, pools of urine from healthy females and males respectively. 
Rectangles and numbers indicate the bands that have been cut and identified by ESI-Q-TOF. 
 
2DE and differential proteomics study 
Figure 6 reports representative 2DE obtained from healthy 
(Figure 6a) and CKD entire cats (Figure 6b). Out of the 66 spots 
detected, 27 showed differential expression (P<0.05) between healthy 
and CKD samples; in particular, 18 spots were overrepresented in the 
CKD group and nine spots were more evident in healthy animals. The 
remaining 39 spots were common and had similar expression levels. 
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The nine most abundant common spots and the 27 differentially 
expressed spots were excised from the gels for MS identification. 
a)  
b)  
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c)  
Figure 6.2DE  of the urine proteome in (a) healthy and (b) CKD entire cats. White circles: spots 
with significantly greater intensity in healthy than in CKD; black circles: spots with significantly 
greater intensity in CKD; white rectangles: common spots without significant differences. (c) 
Examples of important differentially expressed proteins. 
 
Protein identification by mass spectrometry  
From the 16 bands excised from SDS-PAGE (Figure 5), 14 
proteins were unambiguously identified (Table 3). Out of the 36 2DE 
spots analyzed, 20 yielded significant results by MS, allowing the 
successful identification of 13 different proteins (Figure 6a, b; Table 
3). Albumin, cauxin, haemopexin and alpha-1-microglobulin 
precursor/bikunin (AMBP) were identified in spots characterized by 
different MW and/or isoelectric point. Seven proteins identified in 
SDS-PAGE gel were confirmed by 2DE, namely uromodulin, 
albumin, transferrin, cauxin, haptoglobin, retinol binding protein 
(RBP) and immunoglobulin K light chain (IgK).  
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The identified proteins yielded a preliminary cat urine map, 
including 20 proteins that may be functionally classified as transport 
(25%), immune and cellular response (30%), protein metabolism 
(25%), and cellular communication and growth (15%) (Figure 7a). 
Most of the identified proteins were classified as extracellular (75%) 
(Figure 7b).  
 
a)  
b)  
Figure 7. Classification of the proteins identified according to Gene Ontology and the 
Human Reference Proteome Database (HRPD). a) Biological process; b) localization. 
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Table 3. Proteins identified in cat urine by mass spectrometry. 
Band a 
1DE Entry name 
b
 Protein full name MW 
c
 
(kDa) pI Score 
d
 Pept. e Seq.f Sign. Seq. g Identity 
h
 
1 TRFE_BOVIN Serotransferrin 79.9 6.75 88 15 7 3 73 
2 
EST5A_FELCA Carboxylesterase 5A 60.9 5.58 238 27 10 6 100 
ALBU_FELCA Serum albumin 70.6 5.46 135 21 8 6 100 
3 
ALBU_FELCA Serum albumin 70.6 5.46 346 37 16 10 100 
EST5A_FELCA Carboxylesterase 5A 60.9 5.58 41 8 4 2 100 
4 
KV1_CANFA Ig kappa chain V region GOM 12.1 6.41 91 3 2 1 71 
ALBU_FELCA Serum albumin 70.6 5.46 59 9 6 2 100 
5 ALBU_FELCA Serum albumin 70.6 5.46 1340 115 34 25 100 
6 RET4_HORSE Retinol-binding protein 4 23.3 5.28 1121 42 6 4 93 
7 CYTM_HUMAN Cystatin-M 16.5 7.0 71 3 2 1 79 
8 
A2MG_BOVIN Alpha-2-macroglobulin 168.9 5.71 121 9 4 1 75 
ALBU_FELCA Serum albumin 70.6 5.46 115 18 9 4 100 
9 ITIH4_HUMAN Inter-alpha-trypsin inhibitor heavy chain H4 103.5 6.51 70 9 2 2 73 
10 
ACE2_FELCA Angiotensin-converting 
enzyme 2 93.1 5.64 178 15 6 5 100 
UROM_CANFA Uromodulin 72.9 4.94 112 20 4 4 86 
EGF_FELCA Pro-epidermal growth factor 137.3 5.8 83 13 7 4 100 
11 
ALBU_FELCA Serum albumin 70.6 5.46 147 24 11 7 100 
EST5A_FELCA Carboxylesterase 5A 60.9 5.58 145 20 8 2 100 
12 
HPT_CANFA Haptoglobin 36.9 5.72 80 27 8 6 90 
EST5A_FELCA Carboxylesterase 5A 60.9 5.58 102 16 7 3 100 
13 IGLL5_HUMAN Immunoglobulin lambda-like polypeptide 5 23.4 9.08 115 16 1 1 100 
14 
EST5A_FELCA Carboxylesterase 5A 60.9 5.58 254 30 12 6 100 
TRFE_PIG Serotransferrin 78.9 6.93 71 19 7 4 74 
15 
ALBU_FELCA Serum albumin 70.6 5.46 532 53 22 17 100 
EST5A_FELCA Carboxylesterase 5A 60.9 5.58 439 68 16 9 100 
16 
ALBU_FELCA Serum albumin 70.6 5.46 5932 346 51 42 100 
EST5A_FELCA Carboxylesterase 5A 60.9 5.58 1941 157 24 23 100 
A1AT_CHLAE Alpha-1-antitrypsin 44.6 5.75 109 11 3 2 71 
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Spot a 
2DE Entry name 
b
 Protein full name MW 
c
 
(kDa) pI Score 
d
 Pept. e Seq.f Sign. Seq. g Identity 
h
 
1 UROM_CANFA Uromodulin 72.9 4.94 130 36 6 3 86 
2 ALBU_FELCA Serum albumin 70.6 5.46 2383 196 39 28 100 
3 ALBU_FELCA Serum albumin 70.6 5.46 2133 208 35 29 100 
4 EST5A_FELCA Carboxylesterase 5A 60.9 5.58 524 66 14 10 100 
5 EST5A_FELCA Carboxylesterase 5A 60.9 5.58 447 89 14 10 100 
6 TRFE_PIG Serotransferrin 78.9 6.93 114 31 9 5 74 
7 FETUA_HUMAN Fetuin-A 40.1 5.43 141 34 6 4 70 
8 APOH_CANFA Apolipoprotein H 39.7 8.51 162 21 4 4 88 
9 HPT_BOVIN Haptoglobin 45.6 7.83 72 6 2 2 78 
10 AMBP_BOVIN Protein AMBP 40.1 7.81 141 5 1 1 78 
11 AMBP_BOVIN Protein AMBP 40.1 7.81 150 6 1 1 78 
12 AMBP_BOVIN Protein AMBP 40.1 7.81 274 11 1 1 78 
13 PGBM_HUMAN Perlecan 479.3 6.06 134 19 3 2 91 
14 HEMO_PONAB Hemopexin 52.3 6.44 73 25 3 1 83 
15 HEMO_PONAB Hemopexin 52.3 6.44 97 25 3 1 83 
16 ALBU_FELCA Serum albumin 70.6 5.46 1585 187 40 25 100 
17 APOH_CANFA Apolipoprotein H 39.7 8.51 119 16 5 4 88 
18 ALBU_FELCA Serum albumin 70.6 5.46 69 10 7 3 100 
19 
KV1_CANFA Ig kappa chain V region GOM 12.1 6.41 111 4 2 2 71 
CFAD_PIG Complement factor D 28.3 6.59 54 9 2 2 86 
20 RET4_HUMAN Retinol-binding protein 4 23.3 5.76 167 27 8 3 94 
a Number of the identified band or spot as marked in Figure 5 and 6 respectively. 
b
 Protein entry name from UniProt knowledge database. 
c
 Theoretical protein molecular weight. 
d
 The highest scores obtained with Mascot search engine. 
e
 Peptides: total number of peptides  matching the identified proteins. 
f   Sequence: total number of sequences matching the identified proteins. 
g
 Significant Sequences: total number of significant sequences matching the identified proteins. 
h
 Percentage of identical amino acids between the identified protein and the respective cat protein. 
 
Cystatin M (CYSM), RBP, apolipoprotein-H (Apo-H), IgK and 
complement factor D (CFAD) were overrepresented in CKD samples, 
while alpha-2-macroglobulin (A2M), uromodulin, cauxin, inter-alpha-
trypsin inhibitor heavy chain (ITIH4), pro-epidermal growth factor 
(EGF), angiotensin-converting enzyme (ACE2) and perlecan were 
underrepresented (Table 4). Examples of differentially expressed spots 
are reported in Figure 6c. The other proteins did not show significant 
differences between groups.   
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Table 4. Differentially expressed proteins identified by mass spectrometry (ESI-Q-TOF). 
Band a 
SDS-
PAGE 
Entry name b Protein full name CKD vs healthy c 
Molecular 
function d Biological process 
e
 
6 RET4_HUMAN Retinol-binding protein 4 Up Transporter Transport 
7 CYTM_HUMAN Cystatin-M Up Protease inhibitor Protein metabolism 
8 A2MG_BOVIN Alpha-2-
macroglobulin Down Protease inhibitor Protein metabolism 
9 ITIH4_HUMAN 
Inter-alpha-trypsin 
inhibitor heavy chain 
H4 
Down Protease inhibitor Protein metabolism 
10 
ACE2_FELCA Angiotensin-
converting enzyme 2 Down 
Protease-
carboxylpeptidase 
activity 
Protein metabolism 
UROM_CANFA Uromodulin Down Unknown Cellular defense 
response 
EGF_FELCA Pro-epidermal growth factor Down 
Growth factor 
activity 
Cell comunication; 
Signal transduction 
Spot a 
2DE 
     
1 UROM_CANFA Uromodulin Down Unknown Cellular defense 
response 
2 ALBU_FELCA Albumin Down Transporter Transport 
4; 5 EST5A_FELCA Carboxylesterase 5A Down Protease-hydrolase activity Unknown 
8; 17 APOH_CANFA Apolipoprotein H Up Transporter Transport 
13 PGBM_HUMAN Perlecan Down 
Extracellular 
matrix structural 
constituent 
cell 
Growth/maintenance 
16; 18 ALBU_FELCA Albumin Up Transporter Transport 
19 
KV1_CANFA Ig kappa chain V 
region GOM Up Antigen binding Immune response 
CFAD_PIG Complement factor D Up Serine-type peptidase Immune response 
20 RET4_HUMAN Retinol-binding protein 4 Up Transporter Transport 
a Number of the identified band or spot as marked in Fig 5 and 6 respectively. 
b
 Protein entry name from UniProt knowledge database. 
c
 Significantly (P<0.05) overrepresented (up) and underrepresented (down) proteins in CKD group 
respect to healthy. 
d
 Molecular function according to Gene Ontology and Human Reference Proteome Database. 
e
 Biological process according to Gene Ontology and Human Reference Proteome Database.  
 
2.2.2.3. DISCUSSIONS 
The first aim of this work was the characterization of the urine 
proteome in healthy cat by three electrophoretic methods and the 
establishment of the urine proteome reference map in cats.  
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HRE allowed a first screening of the urine proteome in cats 
highlighting different pherograms between healthy and CKD and 
significant higher values of albuminuria in CKD cats. In human 
patients proteinuria and albuminuria have been identified as 
independent risk factors for cardiovascular mortality as well as 
diabetic nephropathy and CKD.  Early detection of low levels of 
albuminuria (microalbuminuria) and the early setting of a therapy 
could therefore  slow the progression of the renal damage (Wu et al., 
2012). Some studies suggested the usefulness of microalbuminuria as 
an accurate marker of early renal disease also in dogs (Bacic et al., 
2010; Smets et al., 2010) and cats (Syme et al., 2006; Hanzlicek et al., 
2012). In addition to primary kidney disease, other conditions have 
been reported in dogs with albuminuria, including non-infectious 
inflammatory disease, hyperadrenocorticism and critically ill 
(Whittemore et al., 2006; Vaden et al., 2010; Smets et al., 2012). The 
studies on the prevalence of albuminuria in cats are fragmentary and 
are restricted to cats affected by diabetes mellitus or systemic disease 
(Whittemore et al., 2007; Al-Ghazlat et al., 2011). Due to its simple 
and fast protocol, HRE could be a useful tool to rapidly separate urine 
proteins and to quantify albuminuria particularly when UTP<40 
mg/dL.  More sensitive automatic analyzers and a sensitive method 
specific for cat albumin are needed to quantify low levels of 
albuminuria.  
SDS-PAGE yielded an overall view of the protein profile 
highlighting 32 different bands in healthy samples, different profiles 
in CKD cats and no differences between males and females. In this 
point of view cats are different from dogs: in male dogs urine contains 
significant amounts of arginine esterase (Miller et al., 2014). When 
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coupled to MS, SDS-PAGE allowed the identification of 14 different 
urine proteins, e.g. uromodulin, largely studied in human and 
identified also in dogs (Nabity et al., 2011).  
2DE was essential in fractionation of the complex urine 
proteome producing a reference map that included 20 proteins derived 
from either plasma ultrafiltration or kidney secretion, in accordance 
with data reported in humans (Adachi et al., 2006; Candiano et al., 
2010; He et al., 2012) and dogs (Nabity et al., 2011; Brandt et al., 
2014).  
The most abundant protein was cauxin, a serine esterase 
produced by healthy tubular cells, specifically excreted in urine of cats 
and probably involved in the synthesis of felinine pheromone 
(Miyazaki et al., 2006). Most of the other proteins identified were 
involved in protein metabolism, immune response and transport. 
Regarding protein metabolism, we found several protease inhibitors 
(A2M, A1AT, ITIH4) that may play an important role in protecting 
the kidney from proteolytic damage. Among the proteins involved in 
immune and cellular defence response, we identified protein AMPB, 
IgK and uromodulin. Differently from dogs (Nabity et al., 2011; 
Brandt et al., 2014; Miller et al., 2014;) and humans (Lhotta, 2010),  
uromodulin is not the most abundant urine-specific protein in cats. 
The transport proteins, albumin, transferrin, haemopexin and 
haptoglobin all derive from plasma and have been identified as 
common components of urine also from healthy humans (Candiano et 
al., 2010). The presence of high MW plasma proteins, e.g. transferrin 
and A2M, in cat urine could contradict the paradigm of glomerular 
selectivity that should be re-evaluated according to the findings of 
Candiano et al. (2010) and Brandt et al. (2014). However, a possible 
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blood contamination of urine due to cystocentesis cannot be excluded. 
The remaining proteins, EGF, perlecan and fetuin-A, are involved in 
cell communication and growth. In particular, perlecan, a negatively 
charged proteoglycan of the glomerular filtration barrier, has also been 
identified in dog urine (Nabity et al., 2011).  
Regarding the effect of CKD on the urine cat proteome, we 
identified 13 proteins differentially represented that could be studied 
as putative biomarkers of nephropathy (Table 4). Our inclusion 
criteria led to the selection of proteinuric late stage CKD patients and 
based on UPC values a severe glomerular involvement could be 
hypothesized. However, most of these differentially expressed 
proteins are indicative of tubular dysfunction (e.g. RBP, CYSM, 
uromodulin and cauxin).  
Among the overrepresented proteins, RBP is a low MW protein 
belonging to the family of lipocalins and is involved in plasma retinol 
transport. An increase in RBP is considered a biomarker of 
tubulointerstitial damage in humans and a significant correlation 
between urinary RBP and kidney interstitial fibrosis was recently 
demonstrated in CKD patients (Pallet et al., 2014). Elevated RBP in 
case of tubular damage has also been reported in dogs (Smets et al., 
2010; Nabity et al., 2011). On the basis of our results, RBP can be 
considered an appealing marker to diagnose and monitor CKD in cats, 
as previously suggested by van Hoek et al., (2008). CYSM belongs to 
the cystatin family, a class of lysosomal cysteine protease inhibitors, 
and is considered a major regulator of epidermal cornification and 
desquamation (Brocklehurst and Philpott, 2013). To our knowledge, 
CYSM has never been found in urine, while an increase in the more 
widely studied cystatin C has been correlated with tubular dysfunction 
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in humans, dogs (Monti et al., 2012) and cats (Ghys et al., 2014); 
further studies are needed to clarify the role of CYSM in urine. Apo-H 
(beta-2-glycoprotein 1) is a single chain multifunctional 
apolipoprotein also expressed in kidney tubular epithelium and 
involved in clotting mechanisms and lipid metabolism (Klaerke et al., 
1997). The increase in urinary Apo-H in diabetic patients has been 
proposed as a marker of tubular dysfunction (Lapsley et al., 1993), 
and recent studies focused on the increased levels of IgA anti-Apo-H 
in CKD patients (Serrano et al., 2014); the role of this protein in cat 
urine is still unknown. The last two overrepresented proteins in CKD 
cats, namely CFAD and IgK, are involved in the immune response. 
CFAD is a serine protease synthesized mainly by adipocytes and 
macrophages belonging to the alternative complement pathway. The 
only report of this protein in urine regards a significant increase in 
human patients with preeclampsia (Wang et al., 2014).  
Among the underrepresented proteins, significant decreases 
were shown by uromodulin, cauxin and perlecan. Uromodulin is a 95 
kDa glycoprotein exclusively synthesized by the cells of the thick 
ascending limb. Its exact molecular function is still unknown, but it is 
thought to be a potent immuno-regulatory protein: recent studies 
hypothesized that uromodulin entering the renal interstitium through 
the damaged tubules can stimulate the cells of the immune system 
causing inflammation and CKD progression (El-Achkar and Wu, 
2012). The decrease of uromodulin was previously observed also in 
dogs affected by leishmaniasis (Buono et al., 2012), suggesting its use 
as a biomarker of renal damage in small animals. 2DE was essential to 
obtain the separation of albumin from cauxin, demonstrating a 
significant decrease of cauxin, however a possible influence of the 
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entire/neutered status cannot be completely excluded. Though Jepson 
et al., (2010) showed a weak correlation of cauxin with the future 
onset of azotemia, our data, according with Miyazaki et al., (2007), 
suggest  this protein could be considered a promising biomarker for 
the determination of tubular damage in CKD cats particularly in entire 
male cats. The decrease of perlecan in human urine is associated with 
damage in the glomerular compartment (Ebefors et al., 2011) and 
could also suggest glomerular involvement in cats affected by renal 
disease. The remaining underrepresented proteins are involved in 
protein metabolism or cellular defence and communication. In 
particular, the decrease of the protease inhibitors A2M and ITIH4 
could have a role in the pathophysiology of CKD. In support of this 
mechanism, intensive protein degradation has also been reported to 
occur in the urine of humans with CKD (Mullen et al., 2011). This 
finding is in accordance with the increased protein fragmentation, 
especially of albumin, found in our study.  
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2.3. FARM ANIMALS 
 
2.3.1. BOVINE URINE PROTEOME 
 
2.3.1.1. MATERIALS AND METHODS 
Animals and samples 
For the present part of the study dairy cows and heifer were 
selected. The animals were housed  in University Dairy Farm of the 
Department of Veterinary Medical Sciences – University of Bologna. 
The animals were in good health status and periodically underwent to 
physical examination and routine analysis. Urine samples were 
collected in the early morning by manual stimulation of the vulva to 
elicit micturition and collected in clean urine container. Urine samples 
were collected monthly for one year from December 2012 to 
November 2013 and analyzed with the following standardized 
protocol: 
 urinalysis (USG and disptick); 
 centrifugation at 1,500 g for 10 minutes; 
 microscopic analysis of urine sediment; 
 protein quantification with UPC ratio calculation; 
The supernatants were immediately stored at -80 ˚C for the subsequent 
analysis by SDS-PAGE.  
 
Urinalysis (USG, dipstick and sediment) 
Each urine sample underwent complete routine urinalysis 
including determination of the urine specific gravity (USG) by a 
refractometer, semi-quantitative dipstick test (Combur10Test, Roche 
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Diagnostic) and microscopic sediment analysis at low (100x) and high 
(400x) power field. 
 
Protein quantification and urine protein to creatinine ratio (UPC) 
Urine total proteins (UTP) and creatinine were determined 
using commercial kits (Urinary/CSF Protein, OSR6170, and 
Creatinine OSR6178, Olympus/Beckman Coulter) on an automated 
chemistry analyzer (AU 400, Olympus/Beckman Coulter). The UPC 
was calculated with the following formula: UPC = urine protein 
(mg/dL)/urine creatinine (mg/dL).  
 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Urine proteins were separated using the electrophoresis 
NuPAGE system (Thermo Fisher Scientific) on 4-12% 
polyacrylamide gel in 3-(N-morpholino)ethanesulphonic acid (MES) 
buffer with sodium-dodecyl-sulphate (SDS) (Thermo Fisher 
Scientific). Two µg of protein for each sample were loaded. The gels 
were stained with SilverQuest (Thermo Fisher Scientific). After 
staining, each gel was digitalized and the pherogram was obtained 
using GelAnalyzer 2010 software6. 
 
Statistical analysis 
Data were analyzed with statistical software (Excel 2007 and R 
version 2.15.1) and expressed as mean±standard deviation (SD). The 
different variables (UPC, USG and number of bands) were tested for 
normality with Shapiro-Wilk normality test and distribution was 
                                                 
6
 http://www.gelanalyzer.com/ 
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considered normal for P>0.05. Variables non normally distributed 
were normalized by exponential transformation. Variables with 
normal distribution were analyzed by t-test (difference between 
heifers and cows), one way ANOVA (difference between pregnancy 
trimesters) and two way ANOVA (trend analysis difference between 
heifers and cows for each variable). 
 
2.3.1.2. RESULTS 
Animals and samples 
Fourteen dairy cows (8 heifers and 6 cows) were included in the 
study. From the 8 heifers 62 samples and from the 6 cows 35 samples 
were collected respectively. Heifers and cows both showed urine pH 
between 8 and 9 without any significant finding in the sediment 
analysis. Heifers showed mean USG of 1.032±0.006 significantly 
higher (P<0.01) than cows (1.026±0.004) (Figure 1a). The trend of 
USG was not significantly different between the two groups (Figure 
1b), hence USG values of heifers and cows were analyzed together to 
evaluate the difference between the pregnancy trimesters (tr0, before 
pregnancy; tr1,first trimester; tr2, second trimester; tr3, third trimester; 
tr4, post-calving). USG during the second trimester (1.033±0.005) was 
significantly higher (P<0.05) than before pregnancy (1.028±0.003) 
and post-calving (1.026±0.007) (Figure 1c). 
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a) b)  
c)  
Figure 1. Graphs reporting USG data for heifers and cows. a) Comparison between USG data for 
heifers (H) and cows (C) (P<0.05); b) Comparison of USG trends during pregnancy between 
heifers and cows. c) comparison between USG data during pregnancy trimesters. Tr0, before 
pregnancy; tr1,first trimester; tr2, second trimester; tr3, third trimester; tr4, post-calving. Different 
capital cases indicate significant differences (P<0.05). 
 
Mean UPC in heifers was 0.12±0.03, significantly lower than 
cows (0.17±0.06) (P<0.01) (Figure 2a), while the trend was not 
different between groups (Figure 2b). Therefore, considering together 
UPC values of heifers and cows to evaluate differences between 
pregnancy trimesters, values of the second (0.13±0.05) and the third 
(0.11±0.04) trimesters were significantly lower (P<0.05) than values 
before pregnancy (0.18±0.07) and post-calving (0.32±0.4) (Figure 2c). 
Table 1 reported USG and UPC data for heifers and cows during 
pregnancy. 
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Table 1. USG and UPC data for heifers and cows during pregnancy.  
 
UPC  USG 
 
Mean±SD (n) Mean±SD (n) 
 
Heifer  Cow Heifer Cow 
tr0 0.14±0.02 (11) 0.22±0.08 (10) 1.030±0.003 (11) 1.026±0.00 3(10) 
tr1 0.12±0.02 (12) 0.23±0.11 (2) 1.034±0.006 (12) 1.022±0.003 (2) 
tr2 0.11±0.01 (21) 0.19±0.07 (8) 1.034±0.005 (21) 1.029±0.003 (8) 
tr3 0.10±0.03 (12) 0.13±0.04 (12) 1.032±0.007 (12) 1.028±0.005 (12) 
tr4 0.50±0.56 (3) 0.15±0.03 (3) 1.025±0.010 (3) 1.026±0.005 (3) 
Tr0, before pregnancy; tr1,first trimester; tr2, second trimester; tr3, third trimester; tr4, post-
calving. 
 
a) b)  
c)  
Figure 2. Graphs reporting UPC data for heifers and cows. a) Comparison between UPC data for 
heifers (H) and cows (C) (P<0.05); b) Comparison of UPC trends during pregnancy between 
heifers and cows; c) comparison between UPC data during pregnancy trimesters. tr1,first trimester; 
tr2, second trimester; tr3, third trimester; tr4, post-calving. Different capital cases indecate 
significant differences (P<0.05). For a better visualization, SD for heifers during tr4 (0.56) in 
graph (b), has been removed. 
 
SDS-PAGE 
Representative gels and pherograms of urine samples from 
heifers and cows are reported in Figure 3. We separated 17±5 protein 
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bands in the urine of heifers. The majority had a molecular weight 
(MW) between 12 and 67 kDa (Figure 3). Cows presented a 
significant decrease of the total number of bands (13±4) (P<0.05) 
(Figure 4). Nevertheless, the electrophoretic profile was similar with 
some common bands (97, 86, 78, 70, 59, 38, 27, 23, 21 kDa and three 
proteins between 13 e 9 kDa).  
a) b)  
c)  
Figure 3. Representative SDS-PAGE of urine samples of (a) heifers and (b) cows. c) 
Representative pherograms. 
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Figure 4. Comparison of total number of bands between heifers (H) and cows (C) (P<0.05). 
 
Regarding the possible proteome variation during pregnancy, 
non-significant differences were found in the total number of bands 
between trimesters. However, two bands at 67 and 31 kDa were 
absent in non-pregnant specimens (Figure 5). 
 
a) b)  
Figure 5. SDS-PAGE of urine samples of heifers and cows non-pregnant (a) and pregnant (b). 
Arrows indicate bands at 67 and 31 kDa absent in non-pregnant specimens.  
 
2.3.1.3. DISCUSSIONS 
Cows are an important source of income, hence many paper 
focused on the quality of meat and milk (Maulfair et al., 2010). 
However, data on the urinary proteins and their usefulness in clinical 
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practice are fragmentary (Adamu et al., 2007; Defontis et al., 2013; 
Parrah et al., 2013). Therefore, the aim of this study was to evaluate 
the main urine parameters (USG and UPC) and to evaluate the 
application of SDS-PAGE on the urine proteome of dairy cows.  
Regarding USG, the range we measured resulted similar to what 
reported by Parrah et al., (2013) but wider than the range reported by 
The Merck Veterinary Manual (1.030-1.045). Furthermore, heifers 
presented USG values significantly higher than cows, according to the 
different water and food consumption between the two groups  (Spek 
et al., 2012). 
As regards UPC, only Defontis et al., (2013) tested two 
dipsticks to evaluate proteins in cows, but without selecting for age or 
clinical conditions. Data on urine total protein (UTP) in cows are 
scars, however, Adamu et al., (2007) reported low values of UTP 
similar to our data. Our data on UPC as compared with IR for dogs 
and cats can be considered non-proteinurics (UPC<0.2) (Lees et al., 
2005).  
SDS-PAGE enabled the visualization of many protein bands in 
urine from both heifers and cows and the profiles showed some 
common characteristics. First, the most represented bands were 
between 97 and 8-7 kDa according to Pyo et al., (2003) and different 
from what reported in humans (Zheng et al., 2013), rats (Calzada-
García et al., 1996) and cats (Ferlizza et al., 2015). In humans, the 
urine proteome showed a wider distribution of MW range with protein 
at very high MW (>130 kDa), large quantity of small peptides with 
MW<3 kDa, while the most represented proteins have MW included 
in the range of 20-50 kDa  (Zheng et al., 2013) (Figure 6). 
Furthermore, the proteins present in bovine urine proteome are mainly 
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acidic with an isoelectric point (pI) between 3.5 and 5.5 (Pyo et al., 
2003), different from humans that present proteins with a wider range 
of pI (4-12.5) (Zheng et al., 2013) (Figure 6).  
 
 
Figure 6. Proteins MW distribution and pI range in urine of pregnant and non-pregnant women 
(Zheng et al., 2013). 
 
We could not identify the cow urine proteome by MS, as a 
consequence we made only hypothetical identification comparing the 
MW of the protein bands in the gels with data reported in literature for 
humans, dogs and cats.  In particular in human medicine the most 
abundant proteins in urine are: uromodulin, albumin, 
immunoglobulins, alpha-1-antitrypsin, transferrin and haptoglobin. In 
addition, at least other 18 high abundance proteins are present, such as 
retinol-binding-protein (RBP) (He et al., 2012).  
In the present study the band at 97 kDa could be identified as 
uromodulin (Tamm-Horsfall protein), a glycoprotein produced by the 
healthy tubular cells of the kidney which biological function is still 
under investigation (Youhanna et al., 2014). Uromodulin is the most 
abundant protein in urine of humans and dogs and its use as putative 
biomarker of nephropathy has been suggested (Lhotta, 2010; Buono et 
al., 2012). In women the role of uromodulin during pregnancy is still 
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controversial as for the increase of this protein during the second half 
of the pregnancy (Jeyabalan and Conrad, 2007). Differently, in the 
samples analyzed in the present study putative uromodulin is less 
evident than in dogs and humans. 
The band at 70 kDa could be albumin, one of the most 
represented protein in urine of mammals. The MW of albumin is 
slightly different between species and can be present also with 
fragments at different MW due to proteolytic activity in urine (Mullen 
et al., 2011; Ferlizza et al., 2015). As widely discussed for dogs and 
cats, albumin has a MW near the threshold of the glomerular filtration 
barrier and is therefore studied as biomarker of glomerular damage.  
From the comparison between pregnant and non-pregnant cows 
some qualitative difference has been highlighted. In particular two 
bands were absent in non-pregnant specimens at 67 and 31 kDa. 
Pregnancy induces qualitative and quantitative variations in urine and 
serum proteome. Zheng et al., (2013) reported that the urine proteome 
in pregnant women presented 594 unique proteins compared with the 
post-partum urine proteome (Figure 7). Some of them are used in 
human medicine as biomarkers of maternal disease or fetal syndrome, 
e.g. preeclampsia or Down syndrome. Regarding bovine urine 
proteome, only few proteins have been identified as putative early 
biomarkers of pregnancy. The most studied is bPAP (bovine 
pregnancy-associated protein), a 21 kDa protein homologous of the N-
terminal of collagen subunit alpha (Pyo et al., 2003) 
In the present study the band at 67 kDa was absent in samples 
from non-pregnant and present in all samples from pregnant 
specimens. This band could be identified as alpha-fetoprotein (AFP), a 
protein produced by fetal tissues and belonging to a gene family near 
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to albumin (Deutsch, 1991). In a previous study, AFP was detected in 
maternal serum, by means of radio-immunologic assay, to evaluate 
fetal suffering in pregnant cows (Baetz et al., 1981), while no data are 
reported for this protein in urine. The same authors suggest that the 
maternal-fetal transfer of AFP seemed to be minimal also in case of 
placental inflammation or  necrosis. The presence of low amounts of 
the band at 67 kDa seemed to be in according with the data reported 
by Baetz 1981.  
 
Figure 7. Venn diagram of urine proteomes in pregnant and non-pregnant women (Zheng et al., 
2013). 
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2.3.2. HORSE URINE PROTEOME 
 
2.3.2.1. MATERIALS AND METHODS 
Animals and samples 
For this study healthy and diseased horses were selected. The 
healthy group included privately owned horses near Forlì-Cesena. 
Only animals considered healthy on the basis of history and physical 
examination and with no history of urinary tract diseases were 
included. In some of the healthy horses urine samples were collected 
after exercise to evaluate possible influence on the urine proteome. 
The diseased group comprised horses presented to the Veterinary 
Teaching Hospital of the Department of Veterinary Medical Sciences-
University of Bologna for different clinical conditions. All urine 
samples were collected by free catch in clean urine container and 
analyzed with the following standardized protocol: 
 urinalysis (USG and disptick); 
 centrifugation at 1,500 g for 10 minutes; 
 microscopic analysis of urine sediment; 
 protein quantification with UPC ratio calculation; 
The supernatants were immediately stored at -80 ˚C for the subsequent 
analysis by SDS-PAGE.  
 
Urinalysis (USG, dipstick and sediment) 
Each urine sample underwent complete routine urinalysis 
including determination of the urine specific gravity (USG) by a 
refractometer, semi-quantitative dipstick test (Combur10Test, Roche 
Diagnostic) and microscopic sediment analysis at low (100x) and high 
(400x) power field. 
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Protein quantification and urine protein to creatinine ratio (UPC) 
Urine total proteins (UTP) and creatinine were determined 
using commercial kits (Urinary/CSF Protein, OSR6170, and 
Creatinine OSR6178, Olympus/Beckman Coulter) on an automated 
chemistry analyzer (AU 400, Olympus/Beckman Coulter). The UPC 
was calculated with the following formula: UPC = urine protein 
(mg/dL)/urine creatinine (mg/dL).  
 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Urine proteins were separated using the electrophoresis 
NuPAGE system (Thermo Fisher Scientific) on 4-12% 
polyacrylamide gel in 3-(N-morpholino)ethanesulphonic acid (MES) 
buffer with sodium-dodecyl-sulphate (SDS) (Thermo Fisher 
Scientific). Two µg of proteins for each sample were loaded. The gels 
were stained with SilverQuest (Thermo Fisher Scientific). After 
staining, each gel was digitalized and its pherogram was obtained 
using GelAnalyzer 2010 software7. 
 
Statistical analysis 
Data were analyzed with statistical software (Excel 2007 and R 
version 2.15.1) and expressed as mean±standard deviation (SD). The 
different variables (UPC, USG and number of bands) were tested for 
normality with Shapiro-Wilk normality test and distribution was 
considered normal for P>0.05. The different variables (UPC, USG, 
                                                 
7
 http://www.gelanalyzer.com/ 
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number of bands) were compared using the Kruskal-Wallis one-way 
analysis of variance assuming P<0.05 as a significant probability. 
 
2.3.2.2. RESULTS 
Animals and samples 
Sixty-two urine samples were collected from 37 healthy and 25 
diseased horses. The healthy group comprised 17 males and 20 
females, with a mean age of 142±92 months. USG ranged from 1.009 
to 1.048 with a mean of 1.030±0.008 and a median of 1.032.  UPC 
values ranged from 0.04 to 0.17 with a mean of 0.11±0.03 and a 
median of 0.11. No difference was found between males and females 
and between before (n=25) and after (n=12) exercise for both USG 
and UPC.  
The diseased group comprised 25 horses (19 males, 6 females) 
with a mean age of 155±89 months. USG ranged from 1.005 to 1.048 
with a mean of 1.025±0.011 and a median of 1.028 significantly lower 
than healthy (P<0.05) (Figure 1a). UPC values ranged from 0.02 to 
5.5 with a mean of 0.61±1.2 and a median of 0.12, significantly higher 
than healthy (P<0.05) (Figure 1b). The diseased group was further 
divided in proteinurics and non protinurics with cut-off at 0.2. The 
proteinurics were significantly (P<0.05) different from healthy and 
non-proteinurics for both UPC and USG. A summary table is reported 
(Table 1).  
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Table 1. USG and UPC values for healthy, non-proteinuric and proteinuric horses. Different lower 
cases indicate significant difference (P<0.05).  
  
Mean Median SD Range 
UPC 
Healthy 0.11 0.11 a 0.03 0.04-0.17 
Non-proteinurics 0.10 0.10 a 0.02 0.07-0.15 
Proteinurics 1.39 0.60 b 1.82 0.2-5.5 
     
 
USG 
Healthy 1.031 1.032 a 0.008 1.009-1.048 
Non-proteinurics 1.031 1.032 a 0.005 1.023-1.040 
Proteinurics 1.017 1.014 b 0.014 1.005-1.048 
 
a)  b)  
Figure 1. USG (a) and UPC (b) comparison between healthy and diseased horses. 
 
SDS-PAGE 
Representative gels and pherograms of urine samples from 
healthy and diseased horses are reported in Figure 2. We separated 
13±4 protein bands in the urine of healthy animals. The majority had 
an apparent molecular weight (MW) between 12 and 67 kDa. At 90 
kDa an intense and diffused band was evident. Moreover, between 77 
and 54 kDa 6 protein bands were evidenced in most of the healthy 
samples as well as in some of the non-proteinurics diseased horses. 
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a) b)  
c) d)  
Figure 2. Representative gels of urine samples of (a) healthy and (b) diseased horses; c) 
representative pherograms; d) detail of the 6 protein bands between 77 and 54 kDa highlighted in 
healthy samples. NP=non-proteinuric diseased sample 
 
Diseased animals presented a significant increase of the total 
number of bands (19±7) (P<0.05) (Figure 3) and a more variable 
electrophoretic profile particularly the proteinuric subgroup. The non-
proteinuric group showed an electrophoretic profile similar to healthy 
group. Proteinuric horses showed a decrease of the band at 90 kDa 
and the appearance of 2 to 4 protein bands at MW between 90 and 150 
kDa. Moreover proteinurics showed more bands at MW between 49 
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and 17 kDa and the increased intensity of the band at 27 kDa (Figure 
2b). 
 
Figure 3. Comparison of total number of bands between healthy and diseased horses (P<0.05). 
 
2.3.2.3. DISCUSSIONS 
The aim of this research was to evaluate quantitative (UTP, 
UPC) and qualitative (SDS-PAGE) proteinuria in healthy and diseased 
horses.  
Regarding quantitative proteinuria and in particular UTP, our 
data are in accordance with data previously reported in literature for 
healthy horses. Edwards et al., (1989) and Halbmayr and Schusser, 
(2002) reported mean UTP values lower than 20 mg/dL. To quantify 
proteinuria the parameter routinely used in clinical practice that need 
to be evaluated is UPC. Also for this parameter our data (0.17) are 
consistent with data reported by Uberti et al., (2009) and lower than 
the cut-off value used in clinical practice for horses (0.2).  
SDS-PAGE enabled the visualization of many protein bands 
and a characteristic profile in urine of healthy horses according to 
literature (Halbmayr and Schusser, 2002).  In particular, comparing 
the MW of the bands in our samples to literature we can hypothesize 
the identification of the most represented bands and their clinical 
relevance in healthy and diseased horses. Halbmayr and Schusser, 
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(2002) identified a band at 90 kDa as uromdulin and we could 
hypothesize the presence of this protein in the diffuse band at 90 kDa.  
According to data reported in humans (Lhotta, 2010) also in horses the 
putative uromodulin is the most abundant protein in urine of healthy 
specimens. Its biological function is still not completely known but is 
considered an important biomarker of tubular impairment. Diseased 
proteinurics horses showed a decrease of putative uomodulin band 
suggesting its usefulness as biomarker of tubular function also in 
horses.  
 The 6 thin bands at MW between 73 and 57 could be identified 
as albumin and/or transferrin isoforms. In human urine it has been 
reported that albumin undergo different post-translational 
modifications including fragmentation, glycosylation or 
phosphorylation (Candiano et al., 2008).  
The bands at 55 and 27 kDa could correspond to immunoglobulin 
heavy and light chains identified by Halbmayr and Schusser, (2002). 
In general, the presence of these bands in urine is considered as 
indicative of glomerular damage. In our samples, the increase of these 
bands in proteiunurics horses reinforced their identification and could 
suggest glomerular involvement. However, due to the low number of 
proteinuric horses and the great variety of diseases it was not possible 
to correlate other bands to specific disease. Nevertheless,  the 
significant increase of total number of bands let us suggest that SDS-
PAGE could be useful to classify proteinuria in glomerular or tubular, 
similar to what reported for humans, dogs and cats (Abate et al., 
2005). Interestingly, one horse with laminitis, was classified as non 
proteinuric on the basis of UPC value, however the SDS-PAGE 
profile showed an increase in band of putative albumin (64 kDa) and 
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transferrin (77 kDa). On this basis, the patient could be considered 
affected by selective glomerular proteinuria, according to what 
reported by Uberti et al., (2009) that evidenced glomerular 
involvement during laminits.  
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2.4. NON-CONVENTIONAL ANIMALS 
 
2.4.1. INTRODUCTION 
During the years, felids and giraffes underwent a critical 
reduction in the number of specimens leading to the threatened or 
extinction of some species.  The main cause of this reduction is due to 
anthropogenic activities, e.g. the enlargement of urban areas and the 
poaching.  
The International Union for Conservation of Nature (IUCN), in 
1994 wrote up the Red List8 to provide information on the status, trend 
and threats in order to inform and catalyze actions for biodiversity 
conservation. In particular, different species of felids, e.g. Panthera 
tigris, Acinonyx jubatus, are considered as ”Vulnerable” (VU) or 
“Near Threatened” (NT) as well as some sub-species of Giraffa 
camelopardalis e.g. peralta or rothshildi.  
Recently, the increasing interest on welfare and conservation 
leaded to the constitution of specific societies and programs, e.g. Cat 
Specialist Group, IUCN or Serengeti Giraffe Project, for the defense 
and the protection of these species. Therefore, the evaluation of the 
health status of wild animals in natural areas or in zoos is vital for 
their conservation. The collection of biological samples in non-
invasive manner, including fur, feces and urines are preferred, since 
they can be collected without causing stress conditions, that can 
interfere with the accuracy of the analysis and could occasionally lead 
the animal to death (Kelly et al., 2012).   
  
                                                 
8
 http://www.iucnredlist.org/  
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2.4.2. FELIDS URINE PROTEOME 
 
2.4.2.1. MATERIALS AND METHODS 
Animals and samples 
For the present study urine samples were collected from felids 
of different species, age and sex. The animals were housed in four 
different european zoos: Fondazione Bioparco (Rome, Italy), Givskud 
zoo (Give, Denmark), København zoo (Copenhagen, Denmark) and 
zoo de La Palmyre (Les Mathes, France). The animals included in the 
study underwent periodical clinical evaluations by the veterinarian 
staff of the hosting structure. Urine samples were collected in a non 
invasive manner without stressing animals. During the night animals 
were housed in cages with a logline to drain urines that were collected 
the following morning.  
Urine samples were immediately centrifuged at 1,500 g for 10 
minutes, stored at -20°C and sent to the Department of Veterinary 
Medical Sciences - University of Bologna for the subsequent analysis:  
- protein quantification with UPC ratio calculation; 
- SDS-PAGE. 
 
Protein quantification and urine protein to creatinine ratio (UPC) 
Urine total proteins (UTP) and creatinine were determined 
using commercial kits (Urinary/CSF Protein, OSR6170, and 
Creatinine OSR6178, Olympus/Beckman Coulter) on an automated 
chemistry analyzer (AU 400, Olympus/Beckman Coulter). The UPC 
was calculated with the following formula: UPC = urine protein 
(mg/dL)/urine creatinine (mg/dL).  
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Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Urine proteins were separated using the electrophoresis NuPAGE 
system (Thermo Fisher Scientific) on 4-12% polyacrylamide gel in 3-
(N-morpholino)ethanesulphonic acid (MES) buffer with sodium-
dodecyl-sulphate (SDS) (Thermo Fisher Scientific). Two µg of protein 
for each sample were loaded. The gels were stained with SilverQuest 
(Thermo Fisher Scientific). After staining, each gel was digitalized 
and its pherogram was obtained by GelAnalyzer 2010 software9.  
 
Statistical analysis 
Data were analyzed with statistical software (Excel 2007 and R 
version 2.15.1) and expressed as mean±standard deviation (SD). The 
different variables (UTP and UPC) were tested for normality with 
Shapiro-Wilk normality test and distribution was considered normal 
for P>0.05. UTP and UPC, non normally distributed, were normalized 
by exponential transformation. Variables with normal distribution 
were analyzed by one way ANOVA to evaluate differences between 
species assuming P<0.05 as a significant probability. 
 
2.4.2.2. RESULTS  
Fifty-five urine samples were collected from 34 felids of 
different species, age and sex: 10 lions (Panthera leo), 7 tigers 
(Panthera tigris), 8 leopards (Panthera pardus), 4 cheetah (Acinonyx 
jubatus) 3 caracals (Caracal caracal) and 2 jaguar (Panthera onca). 
Table 1 reported data for UTP and UPC for the different species. Only 
caracals showed significant differences compared to the other species. 
                                                 
9
 http://www.gelanalyzer.com/ 
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In particular, UTP values were significantly higher than the values 
measured in tigers (P<0.01) and leopards (P<0.05) (Figure 1a) and 
UPC was significantly higher in caracals than in lions (P<0.01), 
jaguars (P<0.05) and tigers (P<0.05) (Figure 1b). The other species 
did not show significant differences.  
 
Table 1. UTP and UPC values for the felids species analyzed.   
UTP 
(mg/dL) 
Caracals 
(n=3) 
Cheetahs 
(n=4) 
Jaguars 
(n=2) 
Leopards 
(n=8) 
Lions 
(n=10) 
Tigers 
(n=7) 
Mean 313.5 47.9 149.3 88.7 81.9 38.3 
Median 231.8 47.9 81.1 38.9 58.9 36.4 
DS 166.1 20.5 151.1 167.7 61.2 18.7 
 
      
UPC Caracals Cheetahs Jaguars Leopards Lions Tigers 
Mean 1.16 0.33 0.07 0.25 0.14 0.17 
Median 0.69 0.30 0.07 0.12 0.10 0.11 
DS 0.96 0.23 0.01 0.27 0.13 0.16 
 
a) b)  
Figure 1. UTP (a) and UPC (b) comparison among species. Different lower cases indicate 
significant difference (P<0.05).  
 
 
SDS-PAGE 
SDS-PAGE allowed the separation of urine proteome resulting 
in different profiles for each species  
with some common protein bands. Figure 2 reported examples 
of gels and pherograms for each species. Two common bands were 
present at 82 and 64 kDa, while the majority of bands with greater 
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variability among species was present at medium MW, between 62 
and 12 kDa. All species showed also a common diffused band with 
different intensities at 90 kDa and 2 to 5 bands at low MW (<12 kDa). 
Lions, tigers, leopards and jaguars showed 3 to 5 protein bands at high 
MW (>100kDa), while caracals showed two intense bands at 23 and 
17 kDa.  
  
 
a)  
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b)  
Figure 2. Representative (a) gels and (b) pherograms of urine samples of felids.  
 
2.4.2.3. DISCUSSIONS  
For many years, studies on zoo felids focused only on anatomy 
and taxonomy, but now the interest on ethology, genetics, physiology 
and pathophysiology for the conservation of wild felids is increasing 
(Hosey et al., 2009).  
Nationals laws ratify the obligation of clinical evaluation of the 
healthy status by veterinarians, focusing also on the welfare intended 
as reduced man-induced stress.  
The health status evaluation in zoo animals is difficult, clinical 
signs of disease are not always evident and the collection of samples 
can be stressful for the animals, particularly if the restraint is needed. 
Therefore, non-invasive biological samples including fur, feces and 
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urines are preferred, since they can be collected in sufficient amounts, 
and repeatedly with less interferences. The sampling is easy to 
perform and can be standardized reducing the capture-induced stress 
(Kelly et al., 2012). 
In particular, urine samples can be collected from the floor of 
the cages or extracted from snow or sand. Urine does not need 
particular treatments before storage, at least a short centrifugation, and 
can provide important information on endocrine and reproductive 
functions as well as on the general health status (Bechert, 2012). 
More specifically, qualitative (SDS-PAGE) and quantitative (UPC) 
proteinuria are essential for the assessment of kidney function and the 
progression of renal diseases (Grauer, 2011).  
As regards UPC, for cats the cut-off values to classify patients 
as non-proteinucs, borderline proteinurics and proteinurics are 0.2 and 
0.4 (Lees et al., 2005). However for wild felids no data are reported in 
literature. Therefore, assuming the values established for cats as 
reference, lions, tigers and jaguars can be considered non-proteinurics, 
leopards and cheetah borderline proteinurics and caracals proteinurics. 
To our knowledge, our data are the first UPC values reported in big 
cats and further studies are needed to evaluate the influence of sex and 
age on UPC and to establish the interval reference also in these 
species.  
SDS-PAGE allowed the visualization of different profiles for 
each species. Comparing the MW of the protein bands to data reported 
in literature for cats we can hypothesize the identification of the most 
important urine proteins. In particular, as recently reported in cats, the 
band at 64 kDa should contain cauxin. Cauxin is a feline specific 
carboxyl-esterase produced by the epithelial cell of the of the tubule 
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and identified also in lions, tigers and leopards (McLean et al., 2007). 
The same authors reported that cauxin can be present also as polymers 
at high MW (Figure 3) similarly to what can be seen also in our 
samples.   
 
Figure 3. Electrophoresis of urine samples of Asiatic lion (AL), Sumatran tiger (ST), Persian 
leopard (PL), clouded leopard (CL), and jaguar (J) (McLean et al., 2007).  
 
Regarding the band at 90 kDa, present in all species with some 
differences in intensities, could be uromodulin reported as the main 
urine component in healthy humans (Candiano et al., 2010) and dogs 
(Miller et al., 2014) and identified also in cats (Ferlizza et al., 2015).  
Finally, caracals showed an intense band at 17 kDa that, comparing to 
data reported in dogs, could be arginine esterase (Miller et al., 2014).  
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2.4.3. GIRAFFES 
 
2.4.3.1. MATERIALS AND METHODS 
Animals and samples 
For the present study urine samples were collected from giraffes 
(Giraffa camelopardalis) of different sub-species (camelopardalis, 
peralta and rothshildi), age and sex. The animals were housed in two 
different italian zoos: group A) Parco Natura Viva (Verona) and group 
B) Parco Faunistico Le Cornelle (Bergamo). The animals included in 
the study underwent periodical clinical evaluations by the veterinarian 
staff of the respective zoo. Urine samples were collected from the 
ground with a syringe without stressing animals. 
Urine samples were immediately centrifuged at 1,500 g for 10 
minutes, stored at -20°C and sent to the Department of Veterinary 
Medical Sciences-University of Bologna for the subsequent analysis:  
- protein quantification with UPC ratio calculation; 
- SDS-PAGE. 
 
Protein quantification and urine protein to creatinine ratio (UPC) 
Urine total proteins (UTP) and creatinine were determined 
using commercial kits (Urinary/CSF Protein, OSR6170, and 
Creatinine OSR6178, Olympus/Beckman Coulter) on an automated 
chemistry analyzer (AU 400, Olympus/Beckman Coulter). The UPC 
was calculated with the following formula: UPC = urine protein 
(mg/dL)/urine creatinine (mg/dL).  
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Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Urine proteins were separated using the electrophoresis 
NuPAGE system (Thermo Fisher Scientific) on 12% polyacrylamide 
gel in 3-(N-morpholino)ethanesulphonic acid (MES) buffer with 
sodium-dodecyl-sulphate (SDS) (Thermo Fisher Scientific). Two µg 
of protein for each sample were loaded. The gels were stained with 
SilverQuest (Thermo Fisher Scientific). After staining, each gel was 
digitalized and its pherogram was obtained using GelAnalyzer 2010 
software10. 
 
Statistical analysis 
Data were analyzed with statistical software (Excel 2007 and R 
version 2.15.1) and expressed as mean±standard deviation (SD). The 
different variables (UTP, UPC and number of bands) were tested for 
normality with Shapiro-Wilk normality test and distribution was 
considered normal for P>0.05. UTP (normally distributed) was 
analyzed by t-test, while UPC and number of bands (non-normally 
distributed) were analyzed by Wilcoxon test to evaluate differences 
between groups (A and B), age (young and adults) and gender (male 
and female) assuming P<0.05 as a significant probability.  
 
2.4.3.2. RESULTS 
Fifty-one urine samples were collected from 20 giraffes of 
different sub-species (camelopardalis, peralta and rothshildi), age and 
sex. Table 1 reports data for UTP and UPC for the two groups. Group 
B showed significantly higher values of both UTP (P<0.05) (Figure 
                                                 
10
 http://www.gelanalyzer.com/ 
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1a) and UPC (P <0.05) (Figure 1b) than group A. No differences were 
found between males and females and between young and adults.  
 
Table 1. UTP and UPC values for giraffes. 
UTP (mg/dL) Group A (n=29) Group B (n=22) 
Mean 12.1 19.5  
Median 8.4 20.1 
SD 9.4 6.5 
   
UPC Group A Group B 
Mean 0.062  0.096  
Median 0.056 0.081 
SD 0.012 0.038 
 
a) b)   
Figure 1. UTP (a) and UPC (b) comparison between groups. Different lower cases indicate 
significant differences (P<0.05).  
 
 
SDS-PAGE 
Figure 2 reported representative gels and pherograms. SDS-
PAGE allowed the separation of a typical urine pattern characterized 
by 7±2 protein bands. The most evident bands present in all samples 
were at 90 and 64 kDa and 3 bands at MW<14 kDa. Little inter-
individual differences was found in bands between 62 and 14 kDa. No 
significant differences were found between the two groups, ages and 
genders.  
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a)  
b)  
Figure 2. Representative gel (a) and pherograms (b) of urine samples of giraffes.  
 
 
2.4.3.3. DISCUSSIONS 
Wild animals kept in captivity encounter different sources of 
stress including artificial lights, loud noises, temperatures different 
form their natural habitat, reduced movements possibility, forced 
contact with humans and restrictions in their behaviour (Morgan and 
Tromborg, 2007). In these conditions, health status evaluation is 
difficult and indirect methods of health monitoring are now 
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developing (Hosey et al., 2009). As regards quantitative proteinuria 
(UTP and UPC), no data are reported in literature for giraffes. The 
only study on urines of giraffes correlated urine creatinine 
concentration to a diet rich in hay and concentrate. Our data for 
creatinine are lower than those reported by Sullivan et al., (2010) 
probably due to the different diet. 
As regards UPC, since no data are present in literature for wild or 
domestic ruminants, comparing our data to reference values for dogs 
and cats (IRIS11) we can classify our samples as non-proteinurics 
(UPC<0.2). 
SDS-PAGE allowed the visualization of a typical profile with 
common bands to all animals. Differently from dogs, where the 
predominant urine proteins have medium MW (10-80 kDa) (Brandt et 
al., 2014) and from humans (30-69 kDa) (Oh et al., 2004), giraffes 
presented mainly low MW protein bands respect to high MW proteins 
and this profile is more similar to goat (Ozgo et al., 2009) and rat 
(Calzada-García et al., 1996).  
Comparing our data to literature we can hypothesize the identity of 
some of the bands in giraffes urine proteome. In particular, the band at 
90 kDa could be uromodulin, one of the main protein components in 
normal urine of mammals and already identified in humans, rats, dogs, 
cats and also camels (Calzada-García et al., 1996; Nagaraj and Mann, 
2011; Alhaider et al., 2012; Miller et al., 2014; Ferlizza et al., 2015). 
Uromodulin is an importan biomarker of the kidney health status. 
Moreover, since giraffes have hypertension as a para-physiological 
condition and Padmanabhan et al., (2014) showed a correlation of 
uromodulin to hypertension, the comprehension of its role in 
                                                 
11
 http://www.iris-kidney.com/  
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regulation of systemic and kidney blood pressure needs to be 
investigated further.   
The band at 64 kDa should be albumin. Small amounts of this protein 
are physiological in urine of healthy animals and have been identified 
in urine also of camels (Alhaider et al., 2012) and cows (Pyo et al., 
2003).  
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2.5. CONCLUSIONS 
 
2.5.1. COMPANION ANIMALS 
Our work has produced a reference map of the normal urine 
proteome in cats and can be considered the starting point for future 
studies. Moreover, this is the first research linking of 13 differentially 
represented urine proteins with CKD in cats. The different amounts of 
uromodulin, cauxin, CFAD, Apo-H, RBP and CYSM confirmed 
tubulointerstitial damage in CKD cats and suggested that these 
proteins are candidate biomarkers to be investigated further. 
 Regarding the dog urine proteome, we highlighted a specific 
electrophoretic pattern in healthy animals showing important 
differences in patients affected by leishmaniasis. In particular, 
uromodulin could be a putative biomarker of tubular damage and 
albumin was confirmed as a biomarker of glomerular involvement. 
The role of arginine esterase and low MW proteins needs to be 
investigated further.  
Finally, we also validated HRE for the quantification of 
albuminuria in dogs and cats. HRE and SDS-PAGE could be 
considered as useful tools that could help clinicians in the evaluation 
of the kidney function in dogs and cats. Our data on the proteins most 
represented in the cat and dog urine proteomes and their changes in 
pathological conditions could be useful in the advancement of 
research focused on the discovery of new biomarkers for later use in 
clinical practice.  
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2.5.2. FARM ANIMALS 
This study on the horse urine proteome produced a reference 
electrophoretic pattern characterized by an intense band, presumably 
uromodulin, 5 to 6 bands between 77 and 56 kDa, possible isoforms of 
albumin and/or transferrin and other 6 to 8 bands at lower MW. We 
highlighted some differences in proteinuric horses showing the 
decrease of the putative uromodulin band and the appearance of 2 to 4 
protein bands at higher MW and a greater variability in the range of 
MW between 49 and 17 kDa.  
Regarding cows, we highlighted different electrophoretic 
patterns between heifers and cows showing also some interesting 
proteome changes during pregnancy. In particular, putative alpha-
fetoprotein and b-PAP needs to be further investigated. 
Finally, further studies are needed to identify by mass 
spectrometry the most represented bands to produce a reference urine 
profile of healthy horses and cows. The differentially represented 
bands in physiological and pathophysiological conditions needs to be 
investigated further, with particular attention to the better 
characterization of patients affected by kidney damage.  
 
2.5.3. NON-CONVENTIONAL ANIMALS 
Our work produced the first values for UTP and UPC in healthy 
felids and giraffes kept in captivity. Moreover, we highlighted 
species-specific electrophoretic patterns in big felids and giraffes. 
Further studies are needed to identify the most represented bands and 
to evaluate differences in the urine proteomes in animals kept in wild 
natural conditions.  
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